{"meta":{"query_hash":"277401410e68","filters":{"venue":"American Journal of Cardiovascular Drugs"},"cohort_total":64,"direct_labels_cover":0,"predictions_cover":64,"exported":64,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/277401410e68","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Cardiovascular+Drugs"},"results":[{"id":"W1003900968","doi":"10.2165/00129784-200606060-00006","title":"Bedtime Administration of Graded-Release Diltiazem in Patients with Inadequate BP Control","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Delta-Q Technologies (Canada); Canadian Heart Research Centre","funders":"","keywords":"Diltiazem; Bedtime; Medicine; Adverse effect; Ambulatory; Internal medicine; Anesthesia","score_opus":0.0037201546301360595,"score_gpt":0.19482486444820446,"score_spread":0.1911047098180684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1003900968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959936,0.0025865352,0.000066374865,0.000110949724,0.000055344102,0.000024414387,0.000088109446,0.000013513413,0.0010611474],"genre_scores_gemma":[0.9980076,0.0011489197,0.00012255089,0.00019075182,0.000091408314,0.000017462062,0.0001249562,0.0000031034974,0.00029340177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995782,0.00018530255,0.000058500027,0.00003792682,0.00006918857,0.00007085866],"domain_scores_gemma":[0.9988984,0.0004702305,0.00022284593,0.00006892966,0.00006298638,0.00027666925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059501815,0.00040006553,0.0012853703,0.0003661655,0.0004247208,0.00036692398,0.0002937039,0.00048946106,0.0010446745],"category_scores_gemma":[0.0027256163,0.00019422111,0.0006038561,0.00051433436,0.0002482301,0.0004962223,0.00020032706,0.0008243592,0.00017795898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22401538,0.004926026,0.6267637,0.00092743104,0.0010461932,0.0037594896,0.0010596616,0.00033707448,0.019291902,0.00025302995,0.0016376728,0.11598236],"study_design_scores_gemma":[0.00599222,0.05074501,0.93576187,0.000042869182,0.0009227928,0.002120173,0.0005001931,0.0004486784,0.0014829154,0.00006931782,0.0018812427,0.000032809847],"about_ca_topic_score_codex":0.0027157846,"about_ca_topic_score_gemma":0.004533288,"teacher_disagreement_score":0.0027157846,"about_ca_system_score_codex":0.0004682091,"about_ca_system_score_gemma":0.0004764012,"threshold_uncertainty_score":0.0053999424},"labels":[],"label_agreement":null},{"id":"W124523853","doi":"10.2165/00129784-200101040-00003","title":"Patient Self-Monitoring of Oral Anticoagulant Therapy","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Warfarin; Atrial fibrillation; Intensive care medicine; Anticoagulant; Pharmacotherapy; Self-monitoring; Dosing; Anticoagulant therapy; Surgery; Internal medicine","score_opus":0.061679759266556104,"score_gpt":0.35139503303642033,"score_spread":0.2897152737698642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W124523853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059190684,0.9979971,0.00017629852,0.00026139678,0.00016090878,0.000009762277,0.000028026629,0.000008646375,0.00076587923],"genre_scores_gemma":[0.0060894806,0.9921787,0.0005632493,0.0004635277,0.0003322632,0.000021890633,0.000067057816,0.0000017842901,0.00028206987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990381,0.00025379317,0.0002323976,0.00012708206,0.00032307766,0.000025653158],"domain_scores_gemma":[0.9968341,0.0018661106,0.000842453,0.00004587953,0.00033308796,0.00007839311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013020743,0.0006076174,0.0026191294,0.0019145819,0.00016092531,0.00069167826,0.00082126854,0.0008325633,0.0015374281],"category_scores_gemma":[0.00464002,0.00021738249,0.00092645455,0.0016450682,0.00022274231,0.00071435777,0.00034483033,0.0010510705,0.00044261257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019064135,0.0001238776,0.0017926203,0.01697562,0.0006025599,0.00011040537,0.000030357254,0.00010027075,0.0001924476,0.00019996006,0.008799083,0.9708821],"study_design_scores_gemma":[0.0012834114,0.0021300428,0.08521114,0.09460648,0.013278514,0.013272532,0.0003256573,0.0017473339,0.002165214,0.0015669968,0.7842305,0.00018226355],"about_ca_topic_score_codex":0.0012708838,"about_ca_topic_score_gemma":0.0031786694,"teacher_disagreement_score":0.0026191294,"about_ca_system_score_codex":0.00046319573,"about_ca_system_score_gemma":0.00088368513,"threshold_uncertainty_score":0.0068861246},"labels":[],"label_agreement":null},{"id":"W161538956","doi":"10.2165/00129784-200707040-00005","title":"Impact of Weight-Loss Medications on the Cardiovascular System","year":2007,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Weight loss; Overweight; Obesity; Risk factor; Pharmacotherapy; Intensive care medicine; Diabetes mellitus; Adverse effect; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.027601850045885574,"score_gpt":0.35034674951505157,"score_spread":0.322744899469166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W161538956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013582016,0.9987913,0.000058076683,0.00017908045,0.00011555811,0.0000027435221,0.00001356663,0.0000043612376,0.0006994841],"genre_scores_gemma":[0.000621015,0.9985739,0.000144909,0.00018129457,0.00018300141,0.0000027201004,0.000016299666,6.7377243e-7,0.00027615926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997651,0.000035922847,0.00003426651,0.000036090696,0.00011070801,0.000017896065],"domain_scores_gemma":[0.9994923,0.00027253557,0.000091896545,0.000010003126,0.00010303582,0.000030170464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005744973,0.00082934933,0.0020254238,0.0016503251,0.0002258087,0.0007991601,0.0007920272,0.00090417877,0.0035821844],"category_scores_gemma":[0.00074467517,0.00024892428,0.00060848205,0.0018040274,0.00032599323,0.0008209019,0.00048203004,0.0015566138,0.0013848065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013435361,0.00012127678,0.0003289218,0.011350248,0.00021670024,0.00017656288,0.000019268764,0.00022924741,0.00078773184,0.00092308235,0.014269429,0.97144306],"study_design_scores_gemma":[0.00014699418,0.00041133206,0.0077448073,0.008785744,0.0011074014,0.0025726834,0.00009134416,0.00035708805,0.00086392777,0.0019472616,0.9759286,0.000042820557],"about_ca_topic_score_codex":0.0016526302,"about_ca_topic_score_gemma":0.0042184414,"teacher_disagreement_score":0.0035821844,"about_ca_system_score_codex":0.00040124383,"about_ca_system_score_gemma":0.0008606296,"threshold_uncertainty_score":0.011983573},"labels":[],"label_agreement":null},{"id":"W163982164","doi":"10.2165/00129784-200707060-00007","title":"Estimating the Cost Effectiveness of Ramipril used for Specific Clinical Indications","year":2007,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ramipril; Quality-adjusted life year; Life expectancy; Cost effectiveness; Clinical trial; Pharmacoeconomics; Intensive care medicine; Quality of life (healthcare); Internal medicine; Population; Environmental health; Risk analysis (engineering)","score_opus":0.20986678129403516,"score_gpt":0.4450840668693218,"score_spread":0.23521728557528662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W163982164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797754,0.0056853,0.008896852,0.0012972852,0.00006706224,0.0002283172,0.0014964879,0.000054336266,0.0024990356],"genre_scores_gemma":[0.9968733,0.0006925348,0.0017601094,0.000046427656,0.000021802458,0.000039403767,0.0003745656,0.0000030609106,0.0001888625],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782085,0.0016760706,0.000110365916,0.00010364063,0.00013192881,0.00015716797],"domain_scores_gemma":[0.9859044,0.012840864,0.00061301154,0.0001641555,0.00029240947,0.00018510701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046681217,0.001003348,0.0012511904,0.0017356137,0.0001626365,0.0012937302,0.0006963438,0.0013364638,0.002043701],"category_scores_gemma":[0.0207465,0.0004236757,0.0019544044,0.001002152,0.00035363628,0.0011389191,0.0005725842,0.0009334494,0.00014653087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02941684,0.0010590184,0.13451678,0.00118757,0.004758911,0.0005993614,0.000116608004,0.6933298,0.002146707,0.004726141,0.0017694008,0.12637289],"study_design_scores_gemma":[0.0034143187,0.010445627,0.093312785,0.0003716658,0.0072925333,0.00093799474,0.00041103456,0.8706082,0.0039670276,0.007117389,0.0019946366,0.00012672492],"about_ca_topic_score_codex":0.006394286,"about_ca_topic_score_gemma":0.003676229,"teacher_disagreement_score":0.006394286,"about_ca_system_score_codex":0.0023082846,"about_ca_system_score_gemma":0.0013330913,"threshold_uncertainty_score":0.024687648},"labels":[],"label_agreement":null},{"id":"W167127537","doi":"10.1007/bf03256594","title":"Extended Dalteparin Prophylaxis for Venous Thromboembolic Events","year":2009,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Royal Jubilee Hospital; Toronto East General Hospital; Sunnybrook Health Science Centre; Augmentium Pharma Consulting (Canada)","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Warfarin; Pulmonary embolism; Arthroplasty; Knee replacement; Venous thrombosis; Orthopedic surgery; Deep vein; Hip fracture; Hip replacement; Thrombosis; Surgery; Anesthesia; Internal medicine; Atrial fibrillation","score_opus":0.008735250268885322,"score_gpt":0.266173251892355,"score_spread":0.2574380016234697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167127537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94814557,0.034966286,0.0017913871,0.0019574766,0.000265585,0.00006037484,0.0002382435,0.000061501836,0.012513539],"genre_scores_gemma":[0.9950309,0.0026449175,0.00058954203,0.00037765247,0.00020524485,0.0000151163895,0.00012386568,0.0000021011729,0.001010745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99982387,0.00005032533,0.000019995481,0.00001791211,0.00005065217,0.000037279497],"domain_scores_gemma":[0.9996197,0.00014388084,0.00005630619,0.000027983135,0.000022199609,0.00012982915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027098818,0.00020471858,0.0005088642,0.00020404314,0.00015265636,0.00020929117,0.00015807782,0.00025425383,0.0022819345],"category_scores_gemma":[0.0010005253,0.00004772177,0.0002204371,0.0001377451,0.00009094572,0.00023196978,0.00019771028,0.00074188935,0.00018776681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023902835,0.0028376612,0.114839815,0.0006931625,0.0011155204,0.0043671206,0.0001786407,0.0013166595,0.02079901,0.0016608719,0.005229651,0.8230591],"study_design_scores_gemma":[0.009861466,0.02608294,0.8710096,0.0005276841,0.0013324926,0.022387471,0.00017068668,0.004490708,0.0077577867,0.0045267427,0.051791567,0.0000608915],"about_ca_topic_score_codex":0.000204245,"about_ca_topic_score_gemma":0.0005360477,"teacher_disagreement_score":0.0022819345,"about_ca_system_score_codex":0.00017633407,"about_ca_system_score_gemma":0.00036269915,"threshold_uncertainty_score":0.0076338053},"labels":[],"label_agreement":null},{"id":"W172350394","doi":"10.2165/11533430-000000000-00000","title":"Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"Merck; AstraZeneca","keywords":"Rosuvastatin; Simvastatin; Fenofibrate; Medicine; Rosuvastatin Calcium; Pharmacology; Statin; Combination therapy; Internal medicine","score_opus":0.005283008122858314,"score_gpt":0.22650469904548856,"score_spread":0.22122169092263025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W172350394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512273,0.0036757176,0.000092117116,0.00020888873,0.00006877417,0.000043225966,0.00013812061,0.000020205112,0.0006301222],"genre_scores_gemma":[0.99843436,0.00072151417,0.00016428744,0.000118638585,0.0001429614,0.000035565616,0.00015178,0.000004207764,0.00022656297],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990305,0.00045388297,0.00012990132,0.0001530168,0.000105745894,0.00012693307],"domain_scores_gemma":[0.9989102,0.00040021687,0.0002056083,0.00009014404,0.00008044153,0.0003132489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013970354,0.00078086625,0.004118557,0.0005490138,0.00038262823,0.00075188867,0.00041937814,0.00089255354,0.0019871397],"category_scores_gemma":[0.0024323622,0.00045769537,0.001970749,0.0005356399,0.00043160148,0.0009301654,0.00027083475,0.0015296668,0.0003823741],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93939865,0.0025898349,0.014491818,0.00016616091,0.0015905238,0.00012875196,0.000054948163,0.0005070007,0.00566767,0.000047907262,0.00026806796,0.03508866],"study_design_scores_gemma":[0.4058025,0.34453526,0.22424224,0.000107105116,0.0099351965,0.0009239134,0.00031970316,0.006010205,0.005477288,0.00045814217,0.0020378774,0.00015054393],"about_ca_topic_score_codex":0.0008580482,"about_ca_topic_score_gemma":0.001722518,"teacher_disagreement_score":0.004118557,"about_ca_system_score_codex":0.0006916404,"about_ca_system_score_gemma":0.00071376003,"threshold_uncertainty_score":0.0073882937},"labels":[],"label_agreement":null},{"id":"W18416084","doi":"10.2165/00129784-200202050-00005","title":"Prevention of Restenosis with Antioxidants","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Pharmacotherapy; Restenosis; Intensive care medicine; Pharmacology; Internal medicine; Stent","score_opus":0.03257317113756302,"score_gpt":0.3075143393641712,"score_spread":0.2749411682266082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W18416084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039054157,0.9985073,0.0002472319,0.000157965,0.00017624773,0.000007421807,0.000016396627,0.000010845614,0.0004861105],"genre_scores_gemma":[0.0021834197,0.9962871,0.00046936076,0.0002448827,0.00026327383,0.000012114985,0.00003656647,0.0000027389437,0.00050057267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998016,0.000028948743,0.000040600826,0.000044410957,0.000067604604,0.000016840255],"domain_scores_gemma":[0.99964666,0.00017609986,0.00006410404,0.000013374125,0.000076240656,0.000023462138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065710297,0.0011907121,0.0030677828,0.0022044426,0.00028880878,0.00070486026,0.0009794091,0.0011683394,0.0022087386],"category_scores_gemma":[0.00068036595,0.00030126362,0.000848025,0.0014506737,0.00034618314,0.0008019101,0.00033984616,0.0016228729,0.0011529817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042804773,0.00037131488,0.00035738267,0.016612938,0.00036309235,0.00029909887,0.00003659406,0.00020998968,0.0024315317,0.0007630979,0.009339784,0.9687872],"study_design_scores_gemma":[0.0008139932,0.0021653795,0.0080093425,0.009778535,0.0038212033,0.0057137622,0.00014208992,0.00048988283,0.0060869623,0.0027669845,0.9601276,0.0000843689],"about_ca_topic_score_codex":0.00084368594,"about_ca_topic_score_gemma":0.0014535727,"teacher_disagreement_score":0.0030677828,"about_ca_system_score_codex":0.0002511274,"about_ca_system_score_gemma":0.0005124752,"threshold_uncertainty_score":0.0073889494},"labels":[],"label_agreement":null},{"id":"W19483797","doi":"10.2165/00129784-200303001-00004","title":"A Metabolic Approach to the Management of Ischemic Heart Disease","year":2003,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Disease management; Cardiology; Disease; Internal medicine","score_opus":0.007764721654874047,"score_gpt":0.22599666288315945,"score_spread":0.2182319412282854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19483797","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06777539,0.32560304,0.07053285,0.42726228,0.010765658,0.00040511307,0.00025943163,0.000332587,0.09706361],"genre_scores_gemma":[0.46557286,0.34873933,0.06897002,0.062038567,0.033639796,0.0006517676,0.00026970825,0.000070585775,0.020047376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970275,0.00010995649,0.00003473847,0.00002590207,0.00008634297,0.000040265408],"domain_scores_gemma":[0.99975973,0.00006116568,0.000031159347,0.000010627816,0.00006734292,0.000070056005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006196629,0.00061916996,0.0005842558,0.0009544057,0.000730066,0.0010562657,0.00080880657,0.0011954944,0.0018855248],"category_scores_gemma":[0.0009168167,0.00012764848,0.00054697285,0.0003590863,0.0005002755,0.0007767203,0.0009531621,0.003915255,0.00037108656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012260296,0.0029492164,0.012872303,0.0014400437,0.00044366936,0.005056422,0.0002593786,0.0024812534,0.0063831997,0.034370102,0.037672378,0.89484614],"study_design_scores_gemma":[0.0031717075,0.008740916,0.08657709,0.007327751,0.0012895992,0.050715074,0.002256213,0.008707468,0.005749273,0.17419846,0.65098435,0.00028198294],"about_ca_topic_score_codex":0.0010916985,"about_ca_topic_score_gemma":0.0028546413,"teacher_disagreement_score":0.0018855248,"about_ca_system_score_codex":0.00059980276,"about_ca_system_score_gemma":0.0013268137,"threshold_uncertainty_score":0.006307721},"labels":[],"label_agreement":null},{"id":"W1970093780","doi":"10.2165/00129784-200404050-00002","title":"Interactions Between Grapefruit Juice and Cardiovascular Drugs","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; Felodipine; Medicine; Fluvastatin; Nisoldipine; Repaglinide; Nitrendipine; Verapamil; Oral administration; Cisapride; Pharmacokinetics; Chemistry; Nifedipine; Metformin; Endocrinology; Internal medicine; Simvastatin; Insulin; Calcium","score_opus":0.08993227723574834,"score_gpt":0.42836363717711545,"score_spread":0.3384313599413671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970093780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008998776,0.99738365,0.00019081208,0.00012777305,0.000090409936,0.000006554135,0.000027176602,0.000011193876,0.0012625735],"genre_scores_gemma":[0.004455768,0.9935296,0.00033839568,0.00016517383,0.00019205923,0.000009372712,0.00005196801,0.0000015163246,0.0012562252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985945,0.000031758267,0.000017290778,0.000025534919,0.000056325982,0.000009603597],"domain_scores_gemma":[0.9998388,0.00008224879,0.000035782166,0.0000054147704,0.000027729851,0.000009943798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031499064,0.0007089572,0.0013949656,0.0011021674,0.00014857587,0.0004933738,0.00058502227,0.00080226705,0.0026548342],"category_scores_gemma":[0.00041900613,0.00020298714,0.0005791423,0.0009950873,0.00016283839,0.0003783285,0.00027581136,0.0005507575,0.0009560429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024464156,0.00014631652,0.00090865244,0.008300794,0.00042684603,0.00056535774,0.000026704933,0.00037571441,0.003779717,0.00054113043,0.009819935,0.9748643],"study_design_scores_gemma":[0.0001887662,0.0008407072,0.013445308,0.0025096,0.0016187603,0.0060360837,0.00006836886,0.000427455,0.004964809,0.001298695,0.9685554,0.000046045367],"about_ca_topic_score_codex":0.0013676025,"about_ca_topic_score_gemma":0.0033663327,"teacher_disagreement_score":0.0026548342,"about_ca_system_score_codex":0.00027913693,"about_ca_system_score_gemma":0.000409903,"threshold_uncertainty_score":0.008881271},"labels":[],"label_agreement":null},{"id":"W1977491200","doi":"10.2165/00129784-200303010-00001","title":"Does Ischemic Preconditioning Afford Clinically Relevant Cardioprotection?","year":2003,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cardioprotection; Ischemic preconditioning; Pharmacotherapy; Cardiology; Intensive care medicine; Internal medicine; Ischemia","score_opus":0.011532744234204096,"score_gpt":0.29447606598736226,"score_spread":0.2829433217531582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977491200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005897209,0.9966781,0.00017809404,0.0007389854,0.00042427765,0.000007884428,0.00003137269,0.000012485682,0.0013391306],"genre_scores_gemma":[0.0028087874,0.9951149,0.00020359784,0.0006584386,0.0005976522,0.00001576336,0.000037032085,0.0000023897937,0.0005612924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983776,0.000030100264,0.000034765933,0.000031777847,0.000042514133,0.000022935528],"domain_scores_gemma":[0.99956685,0.00021575614,0.000103063365,0.00002219416,0.000058263908,0.000033792807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085154816,0.00089386676,0.0027901053,0.0006662076,0.00023837686,0.0009992684,0.0008610582,0.0014860831,0.0036374466],"category_scores_gemma":[0.0011643448,0.00023416574,0.00045168464,0.00080798933,0.00060745905,0.001376132,0.00035706288,0.0015102179,0.0019127696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078778225,0.00023070099,0.00025097033,0.012041493,0.00014035677,0.00029741143,0.000034715766,0.00012385484,0.00542014,0.0021752592,0.021058558,0.9574387],"study_design_scores_gemma":[0.00090064073,0.0023480696,0.006600974,0.00816887,0.0014068137,0.0036893655,0.00017852314,0.00019197741,0.00647905,0.005299484,0.9646726,0.00006363927],"about_ca_topic_score_codex":0.00031419584,"about_ca_topic_score_gemma":0.0010892593,"teacher_disagreement_score":0.0036374466,"about_ca_system_score_codex":0.0002552095,"about_ca_system_score_gemma":0.0009142277,"threshold_uncertainty_score":0.012168407},"labels":[],"label_agreement":null},{"id":"W1982900042","doi":"10.2165/00129784-200606060-00003","title":"Intensive Reduction of Low-Density Lipoprotein-Cholesterol","year":2006,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Cholesterol; Statin; Coronary artery disease; Internal medicine; Randomized controlled trial; Pharmacotherapy; Placebo; Disease; Clinical trial; Cardiology; Intensive care medicine; Pathology","score_opus":0.014788466981190329,"score_gpt":0.28239048422067486,"score_spread":0.2676020172394845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076951185,0.99760723,0.00024179729,0.00023935069,0.00020171174,0.000014910919,0.000030043024,0.000017024908,0.0008784126],"genre_scores_gemma":[0.004132832,0.99404836,0.00044237528,0.00050812477,0.00027110285,0.000019573707,0.000065147266,0.0000030904368,0.0005094212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998079,0.000036498153,0.00003909009,0.000036264722,0.00006212513,0.000018218203],"domain_scores_gemma":[0.9997002,0.00014528359,0.00008127937,0.000010070839,0.000039238894,0.00002404076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047767715,0.0008263651,0.0030219117,0.0010950081,0.00013476166,0.00042717103,0.0007960981,0.0007366791,0.0029767416],"category_scores_gemma":[0.00068592886,0.0002004998,0.0007209483,0.00091502815,0.00024722604,0.00046098477,0.00033489964,0.0015054997,0.00095835386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008413423,0.00032110355,0.00028231821,0.020090772,0.00059077394,0.00015357076,0.00002005711,0.00015228153,0.0013676522,0.0004121025,0.01181287,0.9639551],"study_design_scores_gemma":[0.0030767056,0.0036563587,0.019919144,0.020966103,0.007912956,0.005026175,0.00011483578,0.00066175405,0.0041336087,0.0018195,0.9326117,0.0001011821],"about_ca_topic_score_codex":0.00076821423,"about_ca_topic_score_gemma":0.001749369,"teacher_disagreement_score":0.0030219117,"about_ca_system_score_codex":0.0002728889,"about_ca_system_score_gemma":0.0005575181,"threshold_uncertainty_score":0.009958208},"labels":[],"label_agreement":null},{"id":"W1984187124","doi":"10.2165/00129784-200101060-00004","title":"Contemporary Management of Children with Atrial Septal Defects","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intracardiac injection; Percutaneous; Surgery; Median sternotomy; Thoracotomy; Septum secundum; Shunt (medical); Volume overload; Cardiology; Internal medicine; Heart failure","score_opus":0.018450823425656227,"score_gpt":0.2756742241101734,"score_spread":0.25722340068451716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984187124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048922194,0.9984988,0.00016833386,0.00026956378,0.00010995296,0.000002704952,0.000008828437,0.000005947545,0.00044661856],"genre_scores_gemma":[0.0019927847,0.99700516,0.00036505618,0.00018583158,0.00026991058,0.0000046793143,0.000028159655,9.9242e-7,0.00014743365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997248,0.000042954136,0.00006568839,0.000043919703,0.00010186319,0.000020771718],"domain_scores_gemma":[0.99938345,0.00030481227,0.00014307833,0.00001107529,0.00009721873,0.000060363567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005227931,0.00073711446,0.0016344073,0.0018456796,0.00024664286,0.0007161911,0.00087349134,0.00085167715,0.0012715571],"category_scores_gemma":[0.001280995,0.00019919168,0.0005400631,0.0014147285,0.00032311966,0.0011655755,0.00047808507,0.0012409118,0.00052162807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006633089,0.00006387215,0.0020786058,0.0063832514,0.0001236457,0.0015910815,0.00007245266,0.00025238303,0.00048155998,0.00046901623,0.009797789,0.9786202],"study_design_scores_gemma":[0.00020094519,0.0006526825,0.032396533,0.023536975,0.001712423,0.06660124,0.00074374233,0.00072742865,0.0011468844,0.0029533692,0.8692166,0.00011113567],"about_ca_topic_score_codex":0.00096714264,"about_ca_topic_score_gemma":0.0024379708,"teacher_disagreement_score":0.0018456796,"about_ca_system_score_codex":0.00038029836,"about_ca_system_score_gemma":0.0008937253,"threshold_uncertainty_score":0.004253745},"labels":[],"label_agreement":null},{"id":"W1984682492","doi":"10.2165/00129784-200707010-00006","title":"Current Management of Transient Ischemic Attack","year":2007,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Carotid endarterectomy; Dipyridamole; Stroke (engine); Stenosis; Cardiology; Internal medicine; Magnetic resonance imaging; Endarterectomy; Carotid stenting; Surgery; Radiology","score_opus":0.029724797353770288,"score_gpt":0.33460145725482254,"score_spread":0.3048766599010523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984682492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012229741,0.9982912,0.0001552608,0.000377153,0.00029401795,0.000005418405,0.000012028711,0.000012348845,0.0007301891],"genre_scores_gemma":[0.0013264373,0.9963644,0.00032248997,0.0006675686,0.00086357706,0.000013171582,0.00004522965,0.0000025484792,0.00039454197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995883,0.00006939135,0.00010224439,0.000068707566,0.00013468578,0.000036731995],"domain_scores_gemma":[0.99938047,0.00028495226,0.000155397,0.000013418736,0.0001118429,0.00005388312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006427535,0.0011360332,0.0032422335,0.0028433884,0.00031540773,0.0010467905,0.0012310304,0.0013221425,0.003466781],"category_scores_gemma":[0.0016496904,0.0003322756,0.000896305,0.0017018337,0.00040861417,0.0013938627,0.0005799629,0.0020638343,0.0015398903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013234468,0.00009020098,0.00039601984,0.011285473,0.00014890687,0.000394468,0.000031003274,0.00017888927,0.00035948606,0.0005240272,0.030592488,0.95586675],"study_design_scores_gemma":[0.00038759393,0.0006047994,0.006960249,0.024778277,0.0019077059,0.0097838985,0.00017670066,0.0006277883,0.00055800774,0.0021565938,0.95197874,0.00007968147],"about_ca_topic_score_codex":0.0011612655,"about_ca_topic_score_gemma":0.0025137044,"teacher_disagreement_score":0.003466781,"about_ca_system_score_codex":0.00050868816,"about_ca_system_score_gemma":0.0009820107,"threshold_uncertainty_score":0.011597574},"labels":[],"label_agreement":null},{"id":"W1991953589","doi":"10.1007/s40256-014-0103-2","title":"Erratum to: Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management","year":2015,"lang":"en","type":"erratum","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Thiazide; Medicine; Pharmacotherapy; Calcium channel blocker; Calcium channel; Pharmacology; Calcium; Internal medicine; Diuretic","score_opus":0.02907866525999647,"score_gpt":0.2985489857840086,"score_spread":0.26947032052401215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991953589","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005504612,0.007064911,0.00034276774,0.12322958,0.8620202,0.000053692343,0.0005487124,0.000101652375,0.0060880864],"genre_scores_gemma":[0.014056694,0.023295451,0.0033255331,0.37947014,0.44352755,0.00012530046,0.0011520361,0.00027818084,0.13476914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980405,0.00027038655,0.0006409987,0.00016020835,0.000733701,0.00015418405],"domain_scores_gemma":[0.99097073,0.0028204115,0.0009563972,0.0003672798,0.004186632,0.000698559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019947344,0.0013732767,0.0019282933,0.0022550796,0.001794142,0.0017845605,0.0014613743,0.007380863,0.012835948],"category_scores_gemma":[0.019456187,0.0008996131,0.0017227844,0.0013367451,0.0010671121,0.0016018059,0.0007655761,0.009234771,0.011109183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010649972,0.000034884048,0.0002737836,0.00016953435,0.000025325131,0.0013214599,0.00001590622,0.0000388999,0.00007056563,0.0003724089,0.9863734,0.01119744],"study_design_scores_gemma":[0.0002116237,0.0001513858,0.0023251884,0.00078017905,0.00017339842,0.0030711591,0.00010639261,0.00025455462,0.00046785528,0.000782264,0.9916298,0.000046185127],"about_ca_topic_score_codex":0.007860893,"about_ca_topic_score_gemma":0.015052263,"teacher_disagreement_score":0.012835948,"about_ca_system_score_codex":0.002271694,"about_ca_system_score_gemma":0.0035086416,"threshold_uncertainty_score":0.042940557},"labels":[],"label_agreement":null},{"id":"W1992908766","doi":"10.2165/10061630-000000000-00000","title":"Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"AstraZeneca","keywords":"Dyslipidemia; Medicine; Atorvastatin; Statin; Rosuvastatin; Simvastatin; Internal medicine; Pharmacology; Type 2 Diabetes Mellitus; Fixed-dose combination; Combination therapy; Gastroenterology; Fenofibrate; Adverse effect; Diabetes mellitus; Endocrinology","score_opus":0.005073515122734928,"score_gpt":0.22884284159155013,"score_spread":0.2237693264688152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992908766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588734,0.003137765,0.00009837938,0.0001366862,0.000052168787,0.000042106105,0.00009368422,0.000013855556,0.0005380253],"genre_scores_gemma":[0.9984584,0.0006895777,0.00019364757,0.00013582682,0.00009664623,0.000030149575,0.00015952394,0.000003078258,0.00023321761],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995851,0.0001583578,0.00006320906,0.000071237366,0.00004887167,0.00007325027],"domain_scores_gemma":[0.9994604,0.00014123632,0.00009961306,0.000038437636,0.000046544246,0.00021376747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067434536,0.0006192922,0.0024403762,0.00036760097,0.0004498925,0.0005500378,0.0003724507,0.00067660876,0.0013705224],"category_scores_gemma":[0.001441678,0.00031656906,0.0012921231,0.00033913282,0.00028442437,0.00066145655,0.00026512286,0.0010966507,0.0002834104],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8220505,0.007555359,0.07971038,0.00041071602,0.0029092357,0.000765809,0.00012373859,0.00060659036,0.012025877,0.00010360242,0.0004959059,0.07324234],"study_design_scores_gemma":[0.19270588,0.23550572,0.5371813,0.00025600355,0.011094111,0.0027272261,0.00051582605,0.0058561754,0.009689275,0.0003924231,0.0038845683,0.00019157896],"about_ca_topic_score_codex":0.0010804032,"about_ca_topic_score_gemma":0.0022081397,"teacher_disagreement_score":0.0024403762,"about_ca_system_score_codex":0.00054416945,"about_ca_system_score_gemma":0.00073606014,"threshold_uncertainty_score":0.004584849},"labels":[],"label_agreement":null},{"id":"W1992920746","doi":"10.2165/00129784-200101060-00007","title":"Clopidogrel","year":2001,"lang":"fr","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Pharmacotherapy; Internal medicine; Cardiology; Aspirin","score_opus":0.006937974988336916,"score_gpt":0.2398271040812727,"score_spread":0.23288912909293577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992920746","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07929501,0.055168454,0.0094444,0.022750093,0.0075754803,0.0022433484,0.009639173,0.006254953,0.8076291],"genre_scores_gemma":[0.38368186,0.02563299,0.008663116,0.030961815,0.00452303,0.0015467854,0.017452473,0.00048705426,0.52705085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996406,0.000051363826,0.000022986093,0.000080346654,0.00010126187,0.00010341074],"domain_scores_gemma":[0.9998641,0.00001758353,0.000012150588,0.000023586203,0.000023797413,0.000058719463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002285156,0.00074397546,0.0010859024,0.0007810084,0.00066212926,0.0009917477,0.0005752186,0.0012303015,0.11051106],"category_scores_gemma":[0.0007209421,0.00022541269,0.0007468619,0.00039746577,0.00023902892,0.000337171,0.00055627205,0.0018199526,0.07916047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010744624,0.0024684751,0.0029071958,0.0010822439,0.00046645512,0.003196178,0.00008977273,0.00031621376,0.040983066,0.007163565,0.4279967,0.5025854],"study_design_scores_gemma":[0.0036743057,0.0028989825,0.0073276656,0.00024515876,0.00035045543,0.007827773,0.00004164999,0.0003853462,0.014008876,0.0027729983,0.9604065,0.000060248054],"about_ca_topic_score_codex":0.00046091469,"about_ca_topic_score_gemma":0.00080836355,"teacher_disagreement_score":0.11051106,"about_ca_system_score_codex":0.00031200008,"about_ca_system_score_gemma":0.0007688722,"threshold_uncertainty_score":0.36969632},"labels":[],"label_agreement":null},{"id":"W1996384645","doi":"10.1007/s40256-013-0049-9","title":"New Drug Avenues for Cardioprotection in Patients with Acute Myocardial Infarction","year":2013,"lang":"en","type":"letter","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Cardioprotection; Medicine; Myocardial infarction; Reperfusion injury; Cardiology; Heart failure; Internal medicine; Pharmacology; Ischemia; Intensive care medicine","score_opus":0.0027229400250250784,"score_gpt":0.19613458172095594,"score_spread":0.19341164169593086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996384645","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049472814,0.017962435,0.00032628153,0.93966854,0.014215284,0.000045338882,0.000077864104,0.000050984043,0.02270605],"genre_scores_gemma":[0.056855284,0.027367782,0.001346529,0.7093772,0.18860589,0.00016831027,0.00016970768,0.000029631703,0.016079659],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992638,0.00020222597,0.00012513367,0.00006585433,0.00021736356,0.00012557897],"domain_scores_gemma":[0.9981635,0.0009813912,0.00018285992,0.00005460613,0.00022630267,0.00039132294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085470185,0.00045159724,0.0012957039,0.0005652991,0.0015962776,0.0017962517,0.00072948454,0.013051307,0.005995849],"category_scores_gemma":[0.005095415,0.00029148118,0.001257392,0.00049376383,0.0012462877,0.0015204765,0.00087009376,0.013897615,0.0026810507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088350975,0.0005441612,0.0074587353,0.00045798763,0.00013365928,0.022524524,0.00018666568,0.0003904728,0.0014191293,0.010105421,0.7929519,0.16294378],"study_design_scores_gemma":[0.0022150981,0.0011444486,0.011175378,0.0010913934,0.00027866557,0.021405175,0.00036649694,0.0015442809,0.0007972798,0.021811286,0.93807214,0.000098359546],"about_ca_topic_score_codex":0.00090598024,"about_ca_topic_score_gemma":0.0055791717,"teacher_disagreement_score":0.013051307,"about_ca_system_score_codex":0.0017089832,"about_ca_system_score_gemma":0.0017848101,"threshold_uncertainty_score":0.020058095},"labels":[],"label_agreement":null},{"id":"W1997002994","doi":"10.2165/00129784-200505060-00002","title":"ACE Inhibitors in Heart Failure","year":2005,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Lisinopril; ACE inhibitor; Internal medicine; Heart failure; Cardiology; Hazard ratio; Valsartan; Angiotensin-converting enzyme; Ramipril; Myocardial infarction; Placebo; Blood pressure; Confidence interval","score_opus":0.01400973644410922,"score_gpt":0.2939727673296045,"score_spread":0.27996303088549523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997002994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010253216,0.9986117,0.00006016402,0.00021293007,0.00030340333,0.0000073816323,0.00001772789,0.000005732452,0.0006783762],"genre_scores_gemma":[0.0007757897,0.9975666,0.00013924281,0.00044450717,0.00049078575,0.000010429644,0.000027487784,9.66009e-7,0.0005442599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997185,0.000043234275,0.00006453564,0.000035618457,0.00011287851,0.000025155634],"domain_scores_gemma":[0.99928015,0.00032145338,0.00021829986,0.00001495334,0.00010197794,0.00006309343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006906373,0.00094399916,0.002630344,0.0029639404,0.00024130043,0.0009366035,0.00090149575,0.0010558335,0.005114714],"category_scores_gemma":[0.0012894272,0.00032802246,0.0008123515,0.0023606746,0.00030332542,0.0010320314,0.00066793646,0.0017409845,0.0016149138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025438954,0.00014391539,0.0002477432,0.024515955,0.00035730755,0.00020965362,0.000026143935,0.00014683002,0.00061951275,0.00063065736,0.045349192,0.9274986],"study_design_scores_gemma":[0.00066074607,0.0005369584,0.0046752975,0.018329019,0.0028214112,0.002353862,0.000070231144,0.00028516707,0.00054804556,0.0011402202,0.96853316,0.00004597086],"about_ca_topic_score_codex":0.0012775565,"about_ca_topic_score_gemma":0.004614548,"teacher_disagreement_score":0.005114714,"about_ca_system_score_codex":0.00044011176,"about_ca_system_score_gemma":0.0010271443,"threshold_uncertainty_score":0.017110407},"labels":[],"label_agreement":null},{"id":"W2024206888","doi":"10.1007/s40256-013-0018-3","title":"Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole","year":2013,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Omeprazole; Medicine; Proton-pump inhibitor; Pharmacology; Pharmacodynamics; Pharmacokinetics; Dipyridamole; Aspirin; Drug interaction; CYP2C19; Crossover study; Clopidogrel; Anesthesia; Internal medicine","score_opus":0.004512241784459435,"score_gpt":0.21755519109785537,"score_spread":0.21304294931339593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024206888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988212,0.0004277318,0.00020295793,0.000047446276,0.000016497159,0.00000868133,0.00007071012,0.000015845248,0.00038890922],"genre_scores_gemma":[0.99930155,0.00013066913,0.00014645403,0.000030204028,0.000022005646,0.0000041419653,0.00012731065,0.0000065524628,0.00023116297],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997328,0.0000921429,0.000017049373,0.00004788291,0.000074148425,0.000035961515],"domain_scores_gemma":[0.9996455,0.000093268754,0.00010460608,0.00005547741,0.00001627883,0.000084768675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018895448,0.00022471826,0.0004922642,0.00014226897,0.00014990458,0.00033955064,0.00014660579,0.00027422764,0.0009043244],"category_scores_gemma":[0.001180083,0.00026728472,0.00037730666,0.00016637222,0.00027117864,0.00042231058,0.00010409465,0.00074922404,0.00023731853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19967473,0.0027904164,0.09333362,0.00015286941,0.0016544231,0.0018155187,0.0003606146,0.0018417768,0.5318453,0.00042786365,0.0015805967,0.16452233],"study_design_scores_gemma":[0.007367901,0.07368723,0.8078721,0.00002100243,0.0013211386,0.006340277,0.00016430039,0.00789473,0.089103326,0.0003080471,0.005842366,0.0000775242],"about_ca_topic_score_codex":0.00070984394,"about_ca_topic_score_gemma":0.001265237,"teacher_disagreement_score":0.0009043244,"about_ca_system_score_codex":0.00028635486,"about_ca_system_score_gemma":0.00021931593,"threshold_uncertainty_score":0.0030252337},"labels":[],"label_agreement":null},{"id":"W2026737636","doi":"10.2165/00129784-200808020-00001","title":"Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia","year":2008,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Niacin; Simvastatin; Medicine; Dyslipidemia; Tolerability; Internal medicine; Triglyceride; Lovastatin; Pharmacology; Gastroenterology; Urology; Adverse effect; Endocrinology; Cholesterol; Obesity","score_opus":0.004725128016476281,"score_gpt":0.22181609393772764,"score_spread":0.21709096592125135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026737636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483526,0.004078555,0.00013251159,0.00017546129,0.00003532091,0.00003147375,0.00014447678,0.000019042593,0.00054793997],"genre_scores_gemma":[0.99858814,0.00061110605,0.00011081225,0.00012466872,0.0000734892,0.000024029732,0.00022750969,0.0000029572736,0.00023720138],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99929905,0.00026698384,0.00009706397,0.0001085952,0.00011402103,0.00011420964],"domain_scores_gemma":[0.99876606,0.0003022842,0.00032965577,0.00011669564,0.00010387205,0.00038147563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012172875,0.0005900917,0.0022208674,0.00034574824,0.000460393,0.00060515624,0.0003797826,0.0007787978,0.001207345],"category_scores_gemma":[0.0019792127,0.0003041487,0.0014396721,0.0004659462,0.0004144532,0.00087577855,0.0003039997,0.0015999335,0.00030876845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7300274,0.006194831,0.14542185,0.00038050915,0.0044620503,0.0005581322,0.00019207003,0.00089570077,0.014573599,0.00009143503,0.00051898096,0.09668351],"study_design_scores_gemma":[0.09370752,0.30402815,0.5817803,0.00013208963,0.006540442,0.001545745,0.000360638,0.0033044931,0.005691141,0.0002698219,0.0025050815,0.00013460804],"about_ca_topic_score_codex":0.00073686696,"about_ca_topic_score_gemma":0.0015787625,"teacher_disagreement_score":0.0022208674,"about_ca_system_score_codex":0.0006179169,"about_ca_system_score_gemma":0.00065061933,"threshold_uncertainty_score":0.006437719},"labels":[],"label_agreement":null},{"id":"W2034365627","doi":"10.2165/00129784-200505050-00002","title":"Anticoagulant Use in Patients with Chronic Renal Impairment","year":2005,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Anticoagulant; Anticoagulant therapy; Chronic renal failure; Internal medicine; Cardiology","score_opus":0.02260685290461545,"score_gpt":0.28586271534560936,"score_spread":0.2632558624409939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034365627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006776901,0.99821174,0.00006369275,0.00016487118,0.00013248264,0.0000038058747,0.000027424729,0.0000038093826,0.000714432],"genre_scores_gemma":[0.004455276,0.9945893,0.000170489,0.00022911715,0.00023005645,0.000007506131,0.00004627069,7.2434113e-7,0.0002712173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979454,0.000033956716,0.00006012165,0.000033203087,0.00006386271,0.000014389509],"domain_scores_gemma":[0.9994655,0.0002476469,0.00017077119,0.000008158062,0.00007358134,0.000034371238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038267384,0.0005693704,0.0018835614,0.0022671528,0.00021152606,0.0006064666,0.00046308513,0.0006474831,0.0018463157],"category_scores_gemma":[0.0011441855,0.00017807796,0.00062314805,0.0025419442,0.00019345208,0.00066421746,0.0003430394,0.00078107987,0.0003520615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025703697,0.0001283729,0.0065312404,0.01977689,0.0007248104,0.0005221503,0.000045526445,0.00017607326,0.0005450193,0.00037469613,0.015911037,0.955007],"study_design_scores_gemma":[0.0005857751,0.0009110108,0.08715811,0.041240513,0.009305829,0.018446898,0.00036514198,0.0008956194,0.0012908916,0.0018157589,0.8378404,0.0001440222],"about_ca_topic_score_codex":0.0014340907,"about_ca_topic_score_gemma":0.0035309219,"teacher_disagreement_score":0.0022671528,"about_ca_system_score_codex":0.00026428446,"about_ca_system_score_gemma":0.0008042453,"threshold_uncertainty_score":0.0061765313},"labels":[],"label_agreement":null},{"id":"W2035728262","doi":"10.2165/11587000-000000000-00000","title":"Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study","year":2011,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dr. Georges-L.-Dumont University Hospital Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Perindopril; Tolerability; Internal medicine; Indapamide; Adverse effect; Population; Observational study; Blood pressure","score_opus":0.059910552487420075,"score_gpt":0.28884971815201316,"score_spread":0.22893916566459308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035728262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917334,0.00035629995,0.00008908518,0.00002493413,0.000009255936,0.000038422124,0.00014441212,0.000004485938,0.00015968522],"genre_scores_gemma":[0.99932885,0.0000901299,0.00014320457,0.00007778951,0.00002014621,0.0000315002,0.00020730222,0.000004214366,0.00009694605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960509,0.002001297,0.00034697683,0.0008863808,0.00046270702,0.00025172927],"domain_scores_gemma":[0.99203366,0.0028342656,0.0021100915,0.0014380602,0.0005475732,0.0010363043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039756615,0.00080551545,0.0016419112,0.0005182921,0.00083533145,0.0012066747,0.00095168117,0.0015361337,0.0012617517],"category_scores_gemma":[0.008055268,0.0011604346,0.0020444733,0.0011219179,0.001005026,0.0012891416,0.00076707016,0.0016048576,0.00032115963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048459046,0.0022586677,0.9350703,0.0001950964,0.004878573,0.00030975827,0.00096936885,0.00017038647,0.0032102414,0.000043297754,0.00031970476,0.0041156583],"study_design_scores_gemma":[0.003335817,0.0051134876,0.98950934,0.000013155448,0.0010557844,0.00018486482,0.00019254972,0.0002550108,0.00011317223,0.000027716118,0.00017128472,0.000027906848],"about_ca_topic_score_codex":0.0042488757,"about_ca_topic_score_gemma":0.008014014,"teacher_disagreement_score":0.0042488757,"about_ca_system_score_codex":0.00077039486,"about_ca_system_score_gemma":0.0006699229,"threshold_uncertainty_score":0.021025538},"labels":[],"label_agreement":null},{"id":"W2037319161","doi":"10.2165/00129784-200404050-00005","title":"Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Augmentium Pharma Consulting (Canada); Health Sciences Centre; Toronto East General Hospital; Jewish General Hospital; Royal Jubilee Hospital; Bausch Health (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Fondaparinux; Medicine; Orthopedic surgery; Low molecular weight heparin; Emergency medicine; Surgery; Intensive care medicine; Venous thromboembolism; Heparin; Thrombosis","score_opus":0.0365783578006559,"score_gpt":0.3374377838595827,"score_spread":0.3008594260589268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037319161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002925199,0.9964637,0.000062042585,0.00012255342,0.00005094046,0.000017742846,0.00005370859,0.000002881958,0.00030125567],"genre_scores_gemma":[0.01887169,0.980023,0.00040474455,0.00028205136,0.000106696345,0.00002842639,0.00009931536,0.0000014459106,0.00018255919],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99955076,0.00013261507,0.000113244154,0.000047446712,0.0001352068,0.000020683938],"domain_scores_gemma":[0.9988789,0.0007277806,0.00024956005,0.000012566924,0.00010029201,0.00003090527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009986655,0.0004265511,0.003006093,0.0011833485,0.00014507941,0.00051727786,0.0007092853,0.0005861156,0.0019135143],"category_scores_gemma":[0.0019349535,0.00019410245,0.0014538503,0.0017065981,0.00017361366,0.00030257448,0.00017067185,0.0006420063,0.00015572274],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073916866,0.00044908025,0.0025618367,0.095344186,0.009235282,0.0004590344,0.00006747494,0.0005481772,0.0012578184,0.00044410359,0.0060257968,0.8762155],"study_design_scores_gemma":[0.025813475,0.021714365,0.12621653,0.1037248,0.18928683,0.012436855,0.0006921034,0.0034055922,0.0073612435,0.0031133252,0.5059469,0.0002880095],"about_ca_topic_score_codex":0.0016059031,"about_ca_topic_score_gemma":0.0046010013,"teacher_disagreement_score":0.003006093,"about_ca_system_score_codex":0.000528353,"about_ca_system_score_gemma":0.0008707623,"threshold_uncertainty_score":0.00640136},"labels":[],"label_agreement":null},{"id":"W2041812856","doi":"10.2165/00129784-200202050-00004","title":"Optimizing the Use of Abciximab and Intracoronary Stents in Patients with Acute ST Elevation Myocardial Infarction","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Abciximab; Medicine; Myocardial infarction; Cardiology; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Stent; Angioplasty; Thrombolysis; Revascularization; Restenosis","score_opus":0.022432613515089104,"score_gpt":0.2599481232722334,"score_spread":0.23751550975714428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041812856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007972654,0.9985103,0.00007446448,0.00021810089,0.00008063356,0.0000042690313,0.000009514606,0.0000027544359,0.00030270522],"genre_scores_gemma":[0.0059091714,0.99302953,0.0003031344,0.00031973678,0.0002354715,0.000010002791,0.00003308578,0.0000010141642,0.00015889006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994079,0.00017736689,0.00013763549,0.00006710153,0.00018050792,0.000029553199],"domain_scores_gemma":[0.9990339,0.00058205216,0.0002076458,0.000013929988,0.00012988804,0.000032535056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008823441,0.0007444286,0.003325826,0.0009145531,0.00014717065,0.0005434417,0.0008965454,0.0012421826,0.0011187941],"category_scores_gemma":[0.0023367237,0.00027237058,0.0008224444,0.0011377822,0.00020195085,0.0005604404,0.00023177612,0.0010177895,0.00047416292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007528344,0.00017717722,0.0026945798,0.01830489,0.0009539077,0.0004867351,0.000045885263,0.00044167193,0.0007126847,0.0002898329,0.00837132,0.96676844],"study_design_scores_gemma":[0.0033948878,0.00501449,0.11304505,0.046508744,0.01966427,0.020927867,0.0005408977,0.002277045,0.0036783954,0.0030471175,0.7817061,0.0001950979],"about_ca_topic_score_codex":0.0014069083,"about_ca_topic_score_gemma":0.004317651,"teacher_disagreement_score":0.003325826,"about_ca_system_score_codex":0.00037089203,"about_ca_system_score_gemma":0.0010467676,"threshold_uncertainty_score":0.0046663284},"labels":[],"label_agreement":null},{"id":"W2043229647","doi":"10.2165/00129784-200404010-00001","title":"A Perspective on the Toxicological Mechanisms Possibly Contributing to the Failure of Oral Glycoprotein IIb/IIIa Antagonists in the Clinic","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pharmacotherapy; Pharmacology; Perspective (graphical); Intensive care medicine; P-glycoprotein; Internal medicine; Biochemistry; Multiple drug resistance","score_opus":0.04084037619252233,"score_gpt":0.35544704085723916,"score_spread":0.3146066646647168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043229647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009381025,0.9976618,0.00013135694,0.0007293558,0.000511613,0.0000040003815,0.000016149068,0.0000062456093,0.00084560615],"genre_scores_gemma":[0.00042014496,0.99742484,0.00024011664,0.0005970131,0.000762993,0.000006348254,0.000022158893,9.214971e-7,0.00052556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974376,0.000062729094,0.000041431955,0.000041075276,0.000084376945,0.000026537067],"domain_scores_gemma":[0.9992618,0.00039642886,0.00009279122,0.000016609534,0.00017824504,0.000054184442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011232793,0.0012615588,0.002710142,0.0028167514,0.0004453292,0.0016799778,0.0014628419,0.0024418426,0.005461885],"category_scores_gemma":[0.00093646476,0.00034869552,0.00089936075,0.0023100523,0.00053069665,0.002267227,0.0006367362,0.0025590481,0.0026807294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027242317,0.00023381544,0.0004519908,0.018432181,0.00023324153,0.0018882704,0.00012114706,0.0007418504,0.0024825677,0.0052858805,0.09072996,0.87912667],"study_design_scores_gemma":[0.000079333025,0.0002944225,0.0012036313,0.005436736,0.00030790688,0.0036044843,0.00014862111,0.00019086058,0.00025613751,0.0029017476,0.9855377,0.00003842127],"about_ca_topic_score_codex":0.0013070543,"about_ca_topic_score_gemma":0.0039578504,"teacher_disagreement_score":0.005461885,"about_ca_system_score_codex":0.0007543381,"about_ca_system_score_gemma":0.0012059009,"threshold_uncertainty_score":0.018271804},"labels":[],"label_agreement":null},{"id":"W2062044681","doi":"10.2165/00129784-200303060-00004","title":"Cancer of the Heart","year":2003,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Medical physics; Internal medicine; Cardiology","score_opus":0.016083180398375398,"score_gpt":0.3086130721081177,"score_spread":0.2925298917097423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062044681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000948656,0.99399453,0.00011296089,0.00041471055,0.001098807,0.000009073033,0.000028111514,0.000014963168,0.0042320103],"genre_scores_gemma":[0.0009867541,0.9930496,0.00014006125,0.0007529608,0.00093067274,0.000007291977,0.00007158467,0.0000024271972,0.00405861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981874,0.000023824035,0.00002018598,0.000040127772,0.000071305745,0.000025863877],"domain_scores_gemma":[0.99974483,0.000078236226,0.000050621704,0.00001741818,0.00006656998,0.00004219747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000274046,0.0008640009,0.0014560255,0.0030567704,0.00045972268,0.0011286944,0.00067252555,0.0012102044,0.009982929],"category_scores_gemma":[0.00063977955,0.00030252084,0.0004964269,0.0028766282,0.0005238201,0.0010351874,0.0008193284,0.0018493254,0.006297044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005004521,0.00005796489,0.00030997078,0.004541701,0.00005190051,0.0002392198,0.000023720464,0.00010684541,0.00052763516,0.0015314879,0.11086225,0.8816973],"study_design_scores_gemma":[0.000026335427,0.00004638093,0.00093495013,0.0018923932,0.000080006714,0.0016891684,0.000026225152,0.00004085973,0.0001510776,0.00047269042,0.99463224,0.000007683645],"about_ca_topic_score_codex":0.0026373547,"about_ca_topic_score_gemma":0.0076897833,"teacher_disagreement_score":0.009982929,"about_ca_system_score_codex":0.00059690967,"about_ca_system_score_gemma":0.001321831,"threshold_uncertainty_score":0.033396184},"labels":[],"label_agreement":null},{"id":"W206416980","doi":"10.2165/00129784-200606030-00003","title":"Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Sirolimus; Restenosis; Stent; Angioplasty; Coronary arteries; Internal medicine; Cost effectiveness; Relative risk; Surgery; Artery; Confidence interval","score_opus":0.0050900751739156634,"score_gpt":0.21380329251385716,"score_spread":0.2087132173399415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W206416980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98053944,0.00382313,0.000082824416,0.006533968,0.00007588373,0.000051713185,0.0028114535,0.000016666168,0.0060649407],"genre_scores_gemma":[0.9964684,0.00150522,0.00009627056,0.0003954402,0.000036011985,0.000008714044,0.0006585081,0.000004873739,0.0008265413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990019,0.00014353941,0.00006186177,0.00006834374,0.00028663356,0.0004376951],"domain_scores_gemma":[0.9967301,0.00046052094,0.00046455336,0.000035873203,0.0010482149,0.0012607255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004445501,0.00037031545,0.0007376457,0.0010595669,0.0016307932,0.001838324,0.0012568795,0.0010174158,0.0033246551],"category_scores_gemma":[0.004753453,0.00033119874,0.0011191032,0.002790558,0.00071312155,0.00045376277,0.0006071163,0.0012022542,0.00011775278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052476292,0.00063921715,0.9213374,0.00039711056,0.0010074717,0.0010343464,0.0004030277,0.011904226,0.0004217966,0.0036796057,0.015142769,0.038785364],"study_design_scores_gemma":[0.0009303169,0.00048676273,0.9756527,0.00020607696,0.0009045932,0.0003836926,0.0018793546,0.015474621,0.00022956837,0.00062822684,0.0031351356,0.000088942],"about_ca_topic_score_codex":0.990558,"about_ca_topic_score_gemma":0.9937589,"teacher_disagreement_score":0.070724465,"about_ca_system_score_codex":0.070724465,"about_ca_system_score_gemma":0.060887653,"threshold_uncertainty_score":0.5131443},"labels":[],"label_agreement":null},{"id":"W2067005179","doi":"10.1007/s40256-013-0009-4","title":"Pharmacologic Treatment of Hypertension in Patients With Chronic Kidney Disease","year":2013,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Kidney disease; Etiology; Disease; Intensive care medicine; Blood pressure; Pharmacotherapy; Population; Internal medicine; Kidney","score_opus":0.028158210346119036,"score_gpt":0.2755324716003946,"score_spread":0.24737426125427558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067005179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027248778,0.9992779,0.0000345407,0.00007129233,0.000051864445,0.0000064480782,0.000020862486,0.000002626614,0.0002619415],"genre_scores_gemma":[0.002024866,0.9974239,0.00018090919,0.00018232806,0.00007275294,0.000008492578,0.000027538266,6.5429543e-7,0.00007865156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961686,0.00008995756,0.000112186026,0.000054997927,0.000102753474,0.000023306717],"domain_scores_gemma":[0.9989718,0.0006486672,0.00024675296,0.00001449458,0.000082163286,0.000036077607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090443646,0.00073050545,0.0029561496,0.0018937801,0.00019609305,0.0007166861,0.0010179136,0.00077066803,0.0030163499],"category_scores_gemma":[0.0017448508,0.00033186754,0.0017217852,0.0019127906,0.00028952223,0.0007490844,0.00043811408,0.0014017359,0.0003403017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010196391,0.0002965035,0.0013032916,0.10612183,0.0038098353,0.00019238067,0.00006822911,0.000187095,0.00095586525,0.00063590513,0.010204476,0.8752049],"study_design_scores_gemma":[0.0054942165,0.0045972317,0.04950535,0.15913413,0.062370952,0.0048258957,0.0006512645,0.00080025767,0.0024865544,0.002746197,0.7071292,0.00025870994],"about_ca_topic_score_codex":0.001735773,"about_ca_topic_score_gemma":0.0061496748,"teacher_disagreement_score":0.0030163499,"about_ca_system_score_codex":0.00035386998,"about_ca_system_score_gemma":0.000774002,"threshold_uncertainty_score":0.010090709},"labels":[],"label_agreement":null},{"id":"W2067166093","doi":"10.1007/s40256-014-0087-y","title":"Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management","year":2014,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Servier","keywords":"Medicine; Amlodipine; Blood pressure; Thiazide; Atenolol; Calcium channel blocker; Indapamide; Internal medicine; Pharmacology; Renin–angiotensin system; Aldosterone; Intensive care medicine; Combination therapy; Diuretic; Guideline; Cardiology","score_opus":0.039783797245563524,"score_gpt":0.30328650319669914,"score_spread":0.2635027059511356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067166093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004119301,0.9988219,0.000055620483,0.00010712298,0.00007391341,0.00000851875,0.000031874613,0.0000037835307,0.0004852628],"genre_scores_gemma":[0.002669508,0.99645483,0.00029997464,0.00021609351,0.00008792642,0.00000889233,0.000050847008,0.0000010567995,0.00021082353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980646,0.000038273145,0.000052375035,0.00003150113,0.000055932673,0.00001551101],"domain_scores_gemma":[0.99962306,0.00021475066,0.00008601408,0.0000079206,0.000047372014,0.000020822934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005485067,0.0006653189,0.0022658438,0.0016542028,0.00021522975,0.0006635275,0.00078311074,0.0006366104,0.0049587926],"category_scores_gemma":[0.00082740164,0.00023414163,0.0012275344,0.001616246,0.0002357527,0.000660052,0.00039832148,0.001282146,0.00058600254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008894837,0.00019555583,0.00062916434,0.06706745,0.0020546482,0.00022929761,0.000044019052,0.00020327239,0.0014430608,0.0008405387,0.01218595,0.91421753],"study_design_scores_gemma":[0.003410147,0.002364266,0.014732566,0.06450859,0.02579975,0.004475851,0.00035440156,0.00061180576,0.0022905825,0.0027985051,0.87853336,0.00012014906],"about_ca_topic_score_codex":0.0010201028,"about_ca_topic_score_gemma":0.0042044036,"teacher_disagreement_score":0.0049587926,"about_ca_system_score_codex":0.00026805903,"about_ca_system_score_gemma":0.0005783364,"threshold_uncertainty_score":0.016588748},"labels":[],"label_agreement":null},{"id":"W2079420595","doi":"10.2165/00129784-200303030-00006","title":"New Anticoagulants","year":2003,"lang":"fr","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Argatroban; Medicine; Discovery and development of direct thrombin inhibitors; Fondaparinux; Tissue factor; Hirudin; Factor IXa; Ximelagatran; Dabigatran; Prothrombinase; Thrombin; Direct thrombin inhibitor; Lepirudin; Coagulation; Pharmacology; Rivaroxaban; Thrombomodulin; Tissue factor pathway inhibitor; Anticoagulant; Antithrombin; Factor X; Warfarin; Heparin; Thrombosis; Immunology; Internal medicine; Atrial fibrillation; Platelet; Venous thromboembolism","score_opus":0.026320322877314017,"score_gpt":0.2952242072185761,"score_spread":0.2689038843412621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079420595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002205354,0.9951579,0.00030642902,0.00074840785,0.0009405526,0.0000138068135,0.000027663562,0.000025523468,0.0025592106],"genre_scores_gemma":[0.0016250665,0.9901516,0.00057568186,0.0014058322,0.002098704,0.000029938403,0.00010654916,0.0000047151193,0.0040018344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995915,0.00006389129,0.00007433136,0.00007500342,0.00015606463,0.000039177197],"domain_scores_gemma":[0.99941194,0.0002177755,0.00014767023,0.000029451412,0.000111278925,0.00008191526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008340735,0.0013843378,0.0021910311,0.0037564002,0.00039156817,0.0013104854,0.00092641794,0.0016423872,0.00798903],"category_scores_gemma":[0.0015921867,0.00036258783,0.00075023493,0.0021832671,0.00057865074,0.0014998621,0.00077056995,0.0025131532,0.004309201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019257228,0.00012114227,0.00017362036,0.004029763,0.000091364884,0.0003564878,0.000026017047,0.000118986485,0.0010733348,0.0009962,0.06056644,0.932254],"study_design_scores_gemma":[0.00021241105,0.00035993685,0.00084034604,0.001765835,0.0002996999,0.0025831154,0.000020330712,0.00010638297,0.0005504162,0.0007766881,0.9924671,0.000017608916],"about_ca_topic_score_codex":0.00078785815,"about_ca_topic_score_gemma":0.0020107967,"teacher_disagreement_score":0.00798903,"about_ca_system_score_codex":0.00052641187,"about_ca_system_score_gemma":0.0011834252,"threshold_uncertainty_score":0.026725948},"labels":[],"label_agreement":null},{"id":"W2087243140","doi":"10.1007/bf03256591","title":"Non-Hemodynamic Effects of Organic Nitrates and the Distinctive Characteristics of Pentaerithrityl Tetranitrate","year":2009,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network; Mount Sinai Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Isosorbide dinitrate; Medicine; Isosorbide mononitrate; Angina; Heart failure; Hemodynamics; Intensive care medicine; Cardiology; Pharmacology; Internal medicine","score_opus":0.0033790865087181777,"score_gpt":0.23436425466507746,"score_spread":0.23098516815635928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087243140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013842791,0.99690634,0.00041247066,0.00012310922,0.00012037054,0.000007486221,0.00002251662,0.000008945029,0.0010145552],"genre_scores_gemma":[0.006572605,0.991503,0.0005762535,0.00014345213,0.00016664926,0.000009448727,0.000052901836,0.0000027934727,0.00097291573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987376,0.000016236754,0.000024269413,0.000021025855,0.000051610048,0.00001299648],"domain_scores_gemma":[0.9998099,0.00008019735,0.000052094016,0.000006044726,0.000038132643,0.000013585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033626013,0.00061220996,0.0012814936,0.00079000747,0.00012237129,0.00044451086,0.0007070808,0.00056582794,0.0011897649],"category_scores_gemma":[0.0003161848,0.00019175465,0.00040415986,0.0005316822,0.00035650216,0.00054916606,0.00028555712,0.00088441337,0.0006862532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003592067,0.00022939403,0.000428438,0.015266912,0.00013503603,0.00075614644,0.000060346945,0.000605111,0.032177832,0.0022610603,0.006328574,0.94139194],"study_design_scores_gemma":[0.00019131624,0.0014943932,0.0067365672,0.0026573448,0.00068471534,0.009235265,0.00013298185,0.0007296536,0.036768828,0.002384324,0.93889886,0.00008575078],"about_ca_topic_score_codex":0.0007382122,"about_ca_topic_score_gemma":0.0016773478,"teacher_disagreement_score":0.0012814936,"about_ca_system_score_codex":0.00024981564,"about_ca_system_score_gemma":0.00047300383,"threshold_uncertainty_score":0.0039801598},"labels":[],"label_agreement":null},{"id":"W2183532679","doi":"10.2165/00129784-200202030-00003","title":"Cardiovascular Risk in Patients with Early Renal Insufficiency","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Population; Risk factor; Coronary artery disease; Blood pressure; Creatinine; Incidence (geometry); Renal function; Kidney disease; Stroke (engine); Cardiology","score_opus":0.013921998754039435,"score_gpt":0.23602285559176903,"score_spread":0.2221008568377296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183532679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000801716,0.9986791,0.000030034547,0.000095239004,0.00007887319,0.0000054097795,0.000047512243,0.0000021808305,0.00026000233],"genre_scores_gemma":[0.004324361,0.9951498,0.00013601276,0.00014055047,0.00010305757,0.000011370358,0.0000435594,4.5345263e-7,0.00009077278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999716,0.00006941306,0.00008319833,0.000043865777,0.000073706266,0.000013846964],"domain_scores_gemma":[0.999074,0.0005740466,0.00019861093,0.000014010967,0.00009887337,0.000040438666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080607407,0.00071398483,0.0030905118,0.0019039976,0.00015782028,0.0005925236,0.0004903322,0.00050897506,0.0017808666],"category_scores_gemma":[0.0018382444,0.00022106538,0.0009283198,0.00254615,0.0001632264,0.00051875424,0.00031997904,0.00064840226,0.0002108905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011787177,0.00016709112,0.010581629,0.07726913,0.0039595524,0.00031095426,0.0000736036,0.00018111175,0.0004964736,0.000363341,0.011008927,0.8944094],"study_design_scores_gemma":[0.0027628879,0.002773594,0.23548026,0.1504542,0.07020383,0.0076821246,0.0008633922,0.00065755675,0.0019286935,0.0030160996,0.52392393,0.00025355836],"about_ca_topic_score_codex":0.0017103709,"about_ca_topic_score_gemma":0.0054070926,"teacher_disagreement_score":0.0030905118,"about_ca_system_score_codex":0.00025540133,"about_ca_system_score_gemma":0.0007095112,"threshold_uncertainty_score":0.0059576035},"labels":[],"label_agreement":null},{"id":"W2236378300","doi":"10.1007/s40256-015-0155-y","title":"Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Victoria Heart Institute Foundation","funders":"","keywords":"Clopidogrel; Medicine; Hazard ratio; Drug-eluting stent; Stent; Myocardial infarction; Internal medicine; Confidence interval; Loading dose; Surgery; Cardiology; Percutaneous coronary intervention","score_opus":0.017007200535585007,"score_gpt":0.27220536490736424,"score_spread":0.2551981643717792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236378300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949635,0.0025338463,0.00012618184,0.00034919288,0.00008914023,0.000007833019,0.00026327535,0.000008483732,0.0016583924],"genre_scores_gemma":[0.9980393,0.00086729915,0.00007761588,0.0001601382,0.00024390907,0.0000061835503,0.00031638824,0.000004670358,0.00028447545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992939,0.00014717018,0.00011884143,0.00013230376,0.00013941023,0.00016834424],"domain_scores_gemma":[0.99359316,0.0014116208,0.003457477,0.00044772425,0.0002746482,0.0008154399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006352633,0.00034227208,0.0007466638,0.0005091992,0.00050417543,0.001375473,0.0004544032,0.001177653,0.0022816653],"category_scores_gemma":[0.00488382,0.00032515207,0.0015445682,0.0012940987,0.0005378331,0.00068827544,0.000617677,0.0018575786,0.00033479588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050547677,0.00020834985,0.9824113,0.00011634577,0.0011216133,0.00092840445,0.000115092116,0.00012244123,0.0018160375,0.00014955031,0.00043033983,0.007525569],"study_design_scores_gemma":[0.000028419745,0.0002160472,0.99853945,0.000016919204,0.00027657137,0.00032770765,0.00006444546,0.00012597608,0.00007499447,0.00012451554,0.00019379759,0.0000112765765],"about_ca_topic_score_codex":0.0018560606,"about_ca_topic_score_gemma":0.0036454587,"teacher_disagreement_score":0.0022816653,"about_ca_system_score_codex":0.00036051476,"about_ca_system_score_gemma":0.0006390513,"threshold_uncertainty_score":0.007632911},"labels":[],"label_agreement":null},{"id":"W2306517593","doi":"10.2165/00129784-200202020-00007","title":"Micronized Fenofibrate","year":2002,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Fenofibrate; Medicine; Pharmacotherapy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.008870336507598806,"score_gpt":0.20431284820204446,"score_spread":0.19544251169444565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306517593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96934813,0.005618471,0.0036331213,0.0007122194,0.001017393,0.00020738947,0.0015349033,0.00034632703,0.017582078],"genre_scores_gemma":[0.9723541,0.0019991565,0.0028544846,0.00043211607,0.00010672031,0.00012622665,0.0014365425,0.00002519612,0.020665428],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975723,0.00003056126,0.000021760354,0.000062755855,0.0000595652,0.00006800451],"domain_scores_gemma":[0.99993396,0.000010599581,0.0000089064915,0.000010653089,0.0000138312525,0.000021958529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016233964,0.0002480801,0.00059672707,0.00022422666,0.00023090022,0.000332538,0.00031868453,0.00031731362,0.006703889],"category_scores_gemma":[0.00018828797,0.00010298303,0.0002602286,0.00012134247,0.00024578953,0.00028162778,0.00021826765,0.00059221504,0.0013588059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044446506,0.001783312,0.0014013977,0.00034073554,0.00019640362,0.00061885896,0.00008785305,0.00046729136,0.87608594,0.001755372,0.005092333,0.067723945],"study_design_scores_gemma":[0.0031353626,0.013203341,0.006035759,0.00003753826,0.00025856134,0.0019124658,0.00013572832,0.0015517743,0.90778136,0.00052952784,0.065372996,0.00004565037],"about_ca_topic_score_codex":0.0017523008,"about_ca_topic_score_gemma":0.0017981072,"teacher_disagreement_score":0.006703889,"about_ca_system_score_codex":0.00028686557,"about_ca_system_score_gemma":0.0008455568,"threshold_uncertainty_score":0.022426724},"labels":[],"label_agreement":null},{"id":"W2436268523","doi":"10.1007/s40256-016-0177-0","title":"Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"Canadian Institutes of Health Research; Pfizer Canada; Pfizer","keywords":"Eplerenone; Medicine; Context (archaeology); Heart failure; Cost effectiveness; Intensive care medicine; Spironolactone; Internal medicine; Cardiology","score_opus":0.009846662652232397,"score_gpt":0.23653199499962976,"score_spread":0.22668533234739738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436268523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498766,0.018333666,0.0003140647,0.0097134,0.00031373213,0.00043604316,0.005489851,0.00005271739,0.015469964],"genre_scores_gemma":[0.9893811,0.005412916,0.00040787508,0.0009618621,0.00009503447,0.00004956649,0.0013459777,0.00000876866,0.0023369552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889696,0.00024997976,0.00007118751,0.00006111837,0.00040129278,0.00031942845],"domain_scores_gemma":[0.9980666,0.0002933005,0.00020870859,0.000025028592,0.0005747174,0.0008317545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072574336,0.00042050268,0.00078056235,0.00090465107,0.0011821835,0.001462837,0.0012873374,0.00076727045,0.0030614878],"category_scores_gemma":[0.0029070433,0.00028370396,0.0011653928,0.001695578,0.0006339215,0.00029008064,0.0006666785,0.0010587969,0.000094016796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042661786,0.0038886068,0.5611666,0.0034770328,0.003931804,0.0033099132,0.00071571313,0.02979334,0.0026127582,0.007852985,0.057128657,0.2834608],"study_design_scores_gemma":[0.008398521,0.0035266483,0.9477786,0.0011102135,0.0028595016,0.0008469305,0.0022623292,0.019432291,0.000447825,0.0007827752,0.012392989,0.00016154173],"about_ca_topic_score_codex":0.9863115,"about_ca_topic_score_gemma":0.99324423,"teacher_disagreement_score":0.056897335,"about_ca_system_score_codex":0.056897335,"about_ca_system_score_gemma":0.07899958,"threshold_uncertainty_score":0.412821},"labels":[],"label_agreement":null},{"id":"W2531426511","doi":"10.1007/s40256-016-0196-x","title":"Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Mace; Internal medicine; Hazard ratio; Percutaneous coronary intervention; Acute coronary syndrome; Myocardial infarction; Clinical endpoint; Cardiology; Propensity score matching; Confidence interval; Clopidogrel; Randomized controlled trial","score_opus":0.005686644324525907,"score_gpt":0.24006108513601424,"score_spread":0.23437444081148834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531426511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711454,0.0018748209,0.00007465563,0.00007722832,0.000013458617,0.00008037339,0.00023813009,0.0000015142591,0.0005253258],"genre_scores_gemma":[0.99661285,0.0017781374,0.00018843934,0.00020396206,0.000082102815,0.00010751255,0.0007807801,0.0000017114274,0.0002444461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997129,0.00008989563,0.000056300752,0.000043714466,0.00003303765,0.00006419589],"domain_scores_gemma":[0.99918336,0.00023710364,0.00026528808,0.00005575109,0.000061113446,0.00019736978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000474847,0.00035337743,0.0010772388,0.00048374254,0.00032964416,0.00066003844,0.00025500765,0.00060105283,0.0017642212],"category_scores_gemma":[0.0012748204,0.00026354947,0.0015771915,0.00066413364,0.0002582604,0.00049131707,0.00047582417,0.00067149283,0.00020183784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10100625,0.008619741,0.83682567,0.0010052734,0.006313017,0.0003051307,0.00030809027,0.00054398156,0.0021702321,0.00027375773,0.00081194396,0.041816942],"study_design_scores_gemma":[0.014547981,0.025570493,0.95013845,0.00021397977,0.0052122273,0.0003947938,0.00075021264,0.00060216436,0.00032197926,0.00019985055,0.0020128386,0.00003508726],"about_ca_topic_score_codex":0.0016344758,"about_ca_topic_score_gemma":0.0029275836,"teacher_disagreement_score":0.0017642212,"about_ca_system_score_codex":0.0005613608,"about_ca_system_score_gemma":0.00073507073,"threshold_uncertainty_score":0.005901873},"labels":[],"label_agreement":null},{"id":"W2600702237","doi":"10.1007/s40256-017-0224-5","title":"A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Native Mental Health Association of Canada; University of British Columbia","funders":"","keywords":"Medicine; Spironolactone; Adverse effect; Placebo; Randomized controlled trial; Blood pressure; Internal medicine; Meta-analysis; MEDLINE; Clinical trial; Doxazosin; CINAHL; Intensive care medicine; Heart failure; Alternative medicine","score_opus":0.09402899398896179,"score_gpt":0.36606181885738276,"score_spread":0.27203282486842095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600702237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050435495,0.99896824,0.0000621153,0.00007140167,0.00007583299,0.00006334876,0.00011621932,0.0000033156969,0.00013520046],"genre_scores_gemma":[0.0064565153,0.99263436,0.00032048122,0.0003093236,0.00005954257,0.000066439046,0.00008181079,0.0000018468705,0.00006965827],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99745244,0.000841738,0.0009697747,0.00023399938,0.0004184152,0.0000836303],"domain_scores_gemma":[0.99418783,0.004240573,0.001021902,0.00007528284,0.00038318,0.00009124136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030203664,0.0012109425,0.0077939844,0.003620832,0.000411542,0.0017523784,0.0017543756,0.0014053636,0.005043952],"category_scores_gemma":[0.011937908,0.0006690724,0.008113327,0.0041556596,0.00053093344,0.0014381587,0.0010039619,0.0013869929,0.00027481889],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078464864,0.000041701453,0.00043564412,0.910974,0.027837737,0.00009687542,0.000088390996,0.0001328874,0.00022543852,0.00018952494,0.0016108368,0.05758219],"study_design_scores_gemma":[0.0020890972,0.00082154584,0.006081498,0.5621738,0.39151588,0.0005740655,0.00027058966,0.00016583255,0.00029287953,0.0006003803,0.035327498,0.00008685098],"about_ca_topic_score_codex":0.0067530763,"about_ca_topic_score_gemma":0.023113439,"teacher_disagreement_score":0.0077939844,"about_ca_system_score_codex":0.0014062237,"about_ca_system_score_gemma":0.0034929784,"threshold_uncertainty_score":0.016873717},"labels":[],"label_agreement":null},{"id":"W2602040050","doi":"10.1007/s40256-017-0227-2","title":"The 100 Most Influential Papers in the Field of Thrombolytic Therapy: A Bibliometric Analysis","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Scopus; Medicine; Citation; Bibliometrics; MEDLINE; Library science; Family medicine; Political science; Computer science; Law","score_opus":0.027913649623673105,"score_gpt":0.3564253405306674,"score_spread":0.3285116909069943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602040050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04332451,0.92951673,0.0013286455,0.0015228813,0.00039387555,0.00035630245,0.018038273,0.00013350055,0.0053852424],"genre_scores_gemma":[0.17732769,0.80172896,0.005269545,0.0004350261,0.00086154684,0.0004624727,0.012340025,0.000060409548,0.0015143087],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98966306,0.0014768437,0.003886798,0.0008765051,0.00379953,0.00029724409],"domain_scores_gemma":[0.9585869,0.027235916,0.0065202075,0.00085909537,0.0059932102,0.00080473826],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0060622115,0.001406941,0.0046260217,0.111634664,0.0012586603,0.0032907347,0.0014354959,0.0010464541,0.005212999],"category_scores_gemma":[0.032841656,0.0005810429,0.005129851,0.11444535,0.0008165875,0.00295963,0.001717311,0.0008923332,0.00096023205],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009871548,0.00022764735,0.13590568,0.2693476,0.03157781,0.0010250165,0.0017918834,0.0013894567,0.0018564477,0.0022866905,0.028215371,0.5253892],"study_design_scores_gemma":[0.000585798,0.0006153296,0.49875155,0.091870286,0.13630639,0.006676951,0.00399982,0.002067216,0.002858946,0.0071618613,0.24866003,0.00044578852],"about_ca_topic_score_codex":0.0042567775,"about_ca_topic_score_gemma":0.011071743,"teacher_disagreement_score":0.9939378,"about_ca_system_score_codex":0.0015184126,"about_ca_system_score_gemma":0.005299833,"threshold_uncertainty_score":0.032060385},"labels":[],"label_agreement":null},{"id":"W2613851266","doi":"10.1007/s40256-017-0234-3","title":"66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA","year":2017,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa","keywords":"Medicine; Internal medicine; Pharmacotherapy; Cardiology; Medical education; Family medicine; Medical physics","score_opus":0.015226041359393906,"score_gpt":0.2860716492850451,"score_spread":0.27084560792565116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613851266","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048080585,0.033823024,0.0034618848,0.10255831,0.33347875,0.00088344247,0.0043840082,0.00107151,0.51553094],"genre_scores_gemma":[0.013602432,0.03782311,0.0021251105,0.010304018,0.15144958,0.00056167855,0.0032740105,0.00030321645,0.78055686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991437,0.00013976105,0.000050414892,0.000113372946,0.00038885063,0.00016387818],"domain_scores_gemma":[0.9957535,0.00028814067,0.00023452607,0.00011122848,0.002185297,0.0014272251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027976658,0.0016343271,0.001148063,0.0017893362,0.001259386,0.0032798217,0.0007454967,0.0031710288,0.18324411],"category_scores_gemma":[0.003931049,0.00037126543,0.00074050954,0.000658112,0.0005815845,0.00094277726,0.0014636709,0.0033461815,0.118849084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096828066,0.00010583217,0.0005586404,0.00010326351,0.000017308143,0.00005437009,0.000013697444,0.00006147739,0.00038377222,0.00035372376,0.94271046,0.055540588],"study_design_scores_gemma":[0.00010072797,0.00008962674,0.0068551414,0.00049541803,0.000021827353,0.00013259522,0.000081366954,0.00033681502,0.00022979657,0.0006656395,0.9909724,0.000018566498],"about_ca_topic_score_codex":0.002876571,"about_ca_topic_score_gemma":0.012993861,"teacher_disagreement_score":0.18324411,"about_ca_system_score_codex":0.0009849116,"about_ca_system_score_gemma":0.002953992,"threshold_uncertainty_score":0.6130126},"labels":[],"label_agreement":null},{"id":"W2618833385","doi":"10.1007/s40256-017-0229-0","title":"Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Current (fluid); Pharmacotherapy; Extracorporeal; MEDLINE; Medical physics; Internal medicine; Engineering","score_opus":0.04069440286404368,"score_gpt":0.3171915031520488,"score_spread":0.2764971002880051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618833385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106535685,0.99921095,0.00009701507,0.00021205262,0.00008282516,0.0000028561178,0.000008777659,0.0000038729645,0.0002751017],"genre_scores_gemma":[0.00062797917,0.99865866,0.00021070104,0.00017182263,0.00019073431,0.000004906927,0.000014340574,7.576518e-7,0.00012011682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973685,0.00004377943,0.000058617774,0.000048535723,0.00008595318,0.000026213893],"domain_scores_gemma":[0.9992731,0.00041805432,0.00012957018,0.000013017654,0.00012693231,0.000039200666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008943617,0.00082212116,0.0016852155,0.001567511,0.0002932375,0.0014020443,0.0008816898,0.0011396772,0.0037727908],"category_scores_gemma":[0.0012272245,0.00026866441,0.00083403377,0.0013886528,0.00048683118,0.0014075743,0.0006309406,0.0020688942,0.0010010884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014387496,0.0001533175,0.0004037866,0.022224568,0.00017627458,0.00015506217,0.000053422318,0.00031203177,0.00096482655,0.0023271851,0.012222522,0.9608631],"study_design_scores_gemma":[0.00019474849,0.00066326256,0.0034851395,0.019775528,0.001389219,0.0033060722,0.00026404334,0.00071327714,0.0009825325,0.0059045465,0.96323794,0.00008381214],"about_ca_topic_score_codex":0.00072949496,"about_ca_topic_score_gemma":0.0015835379,"teacher_disagreement_score":0.0037727908,"about_ca_system_score_codex":0.00035406605,"about_ca_system_score_gemma":0.0013303169,"threshold_uncertainty_score":0.0126212835},"labels":[],"label_agreement":null},{"id":"W2799686913","doi":"10.1007/s40256-018-0273-4","title":"Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Myocardial infarction; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Clinical endpoint; Propensity score matching; Cardiology; Ejection fraction; Unstable angina; Revascularization; Heart failure; Acute coronary syndrome; Randomized controlled trial","score_opus":0.016333009582127574,"score_gpt":0.24719895070362996,"score_spread":0.23086594112150238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799686913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747026,0.00039173238,0.00024633296,0.000059932474,0.000019370893,0.000013672542,0.0012124355,0.0000083083,0.00057799625],"genre_scores_gemma":[0.99746287,0.00017212139,0.00010010764,0.000046445683,0.00004388051,0.000018249115,0.0019885374,0.000007653368,0.00016021766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877316,0.00034158307,0.00016632337,0.0003406251,0.00019464601,0.00018366463],"domain_scores_gemma":[0.9975594,0.0005052148,0.0010572794,0.00040009138,0.00022496944,0.0002530094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010774743,0.00036557068,0.0008744698,0.0013104049,0.00038415674,0.0009923521,0.0004218016,0.00063661975,0.0016964484],"category_scores_gemma":[0.0030142257,0.00031748516,0.0016885455,0.0017442536,0.0002786631,0.00067794067,0.0008599476,0.00097282836,0.00025957936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007924592,0.000033317767,0.99687296,0.000013029955,0.00073078356,0.000037621852,0.000016772008,0.0001629267,0.00017543546,0.000047595,0.00028695658,0.00083012227],"study_design_scores_gemma":[0.00009331041,0.00013354477,0.9975752,0.000008318419,0.00051748997,0.00013533511,0.00008623368,0.0010072446,0.00006696693,0.00008712928,0.0002790595,0.0000101845735],"about_ca_topic_score_codex":0.00292191,"about_ca_topic_score_gemma":0.0044817273,"teacher_disagreement_score":0.00292191,"about_ca_system_score_codex":0.00035542456,"about_ca_system_score_gemma":0.00045030485,"threshold_uncertainty_score":0.0058098435},"labels":[],"label_agreement":null},{"id":"W2889103054","doi":"10.1007/s40256-018-0298-8","title":"The Effect of Bromodomain and Extra-Terminal Inhibitor Apabetalone on Attenuated Coronary Atherosclerotic Plaque: Insights from the ASSURE Trial","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Intravascular ultrasound; Medicine; Interquartile range; Internal medicine; Cardiology; Atheroma; Apolipoprotein B; Cholesterol; Vulnerable plaque; Placebo; Rosuvastatin; Population; High-density lipoprotein; Gastroenterology; Pathology","score_opus":0.004287510522323123,"score_gpt":0.21273314523165138,"score_spread":0.20844563470932825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889103054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836179,0.011209756,0.0006843775,0.0007484043,0.00024522748,0.00018273464,0.00056104874,0.000113870534,0.002636693],"genre_scores_gemma":[0.9901945,0.005119498,0.0007705628,0.0006271125,0.0002882145,0.00016593945,0.0006386612,0.000021443066,0.0021741178],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998024,0.00008232906,0.000012946232,0.000025962501,0.000024494128,0.000051715542],"domain_scores_gemma":[0.99968576,0.000088315384,0.000059559126,0.000033151828,0.000022757878,0.00011041823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010930757,0.00058068446,0.0016200984,0.00024727837,0.00027188513,0.000689372,0.0003597214,0.0007266135,0.0020839185],"category_scores_gemma":[0.0008040024,0.00019602988,0.00088931667,0.00023622025,0.00046802373,0.00046435287,0.0002545745,0.0022422993,0.0003546753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78838974,0.008626778,0.002916192,0.00085585774,0.0018344816,0.00019935027,0.00010403517,0.0009772572,0.042112727,0.0012005575,0.00347743,0.14930561],"study_design_scores_gemma":[0.474736,0.44904092,0.03331695,0.00018571087,0.0039502066,0.00062331633,0.00018807451,0.0018479467,0.020964961,0.0018062947,0.013226969,0.00011260218],"about_ca_topic_score_codex":0.0004135638,"about_ca_topic_score_gemma":0.0012015954,"teacher_disagreement_score":0.0020839185,"about_ca_system_score_codex":0.0002734509,"about_ca_system_score_gemma":0.00046353872,"threshold_uncertainty_score":0.006971419},"labels":[],"label_agreement":null},{"id":"W2896677774","doi":"10.1007/s40256-018-0305-0","title":"Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Canadian Heart Research Centre; Southlake Regional Health Center; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Morphine; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Internal medicine; Anesthesia","score_opus":0.006196942118179152,"score_gpt":0.23536688538845008,"score_spread":0.22916994327027093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896677774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758381,0.014175609,0.00018965105,0.0031357915,0.00026064966,0.00009626863,0.0010397389,0.000026015607,0.005238207],"genre_scores_gemma":[0.9885464,0.0075181643,0.00034504556,0.0011048161,0.00050168537,0.000034771067,0.0005909404,0.000010028134,0.0013480812],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990476,0.0003624784,0.00015176334,0.000088776054,0.00019652316,0.00015294385],"domain_scores_gemma":[0.9978998,0.00063641527,0.000827738,0.00009767262,0.00019777472,0.00034061944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089081435,0.00034862105,0.0009187821,0.00020293065,0.00031950074,0.0007571003,0.00046150465,0.00048108376,0.0066384366],"category_scores_gemma":[0.0038330185,0.00018229862,0.0010855218,0.00039468036,0.00026928858,0.0006062348,0.00060618116,0.0010603984,0.00036298748],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23944035,0.0035178412,0.4511111,0.0028375075,0.007739904,0.0015775781,0.0005923183,0.000628234,0.0065766503,0.0016276574,0.012810498,0.27154034],"study_design_scores_gemma":[0.023414899,0.014220374,0.9333967,0.0006591026,0.00820029,0.0013291028,0.0007851487,0.0025334784,0.0006207272,0.0005373366,0.014179409,0.00012344816],"about_ca_topic_score_codex":0.006217623,"about_ca_topic_score_gemma":0.02949409,"teacher_disagreement_score":0.0066384366,"about_ca_system_score_codex":0.0006637018,"about_ca_system_score_gemma":0.0012639746,"threshold_uncertainty_score":0.022207797},"labels":[],"label_agreement":null},{"id":"W2901198550","doi":"10.1007/s40256-018-0309-9","title":"Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; The Quebec Population Health Research Network; Université du Québec à Trois-Rivières; Université Laval; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Abbott Vascular; Institut National de Santé Publique du Québec","keywords":"Medicine; Warfarin; Population; Pharmacotherapy; Brand names; Series (stratigraphy); Advertising; Internal medicine; Atrial fibrillation; Business; Environmental health","score_opus":0.010188573071487614,"score_gpt":0.226260074158103,"score_spread":0.21607150108661538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901198550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964273,0.0014506143,0.00023724105,0.0007108651,0.000026303842,0.00004475356,0.03166119,0.000053235748,0.0015427482],"genre_scores_gemma":[0.98577034,0.0007055938,0.00018803967,0.00016563233,0.000016169819,0.000023058017,0.011466935,0.000012290585,0.001651837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893934,0.000092455346,0.000121025514,0.00020887813,0.00026419354,0.00037406475],"domain_scores_gemma":[0.99638903,0.000295001,0.000830041,0.00014825846,0.0015948638,0.0007429102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084968633,0.0004932144,0.0006219539,0.0017504651,0.0012030677,0.0015557159,0.0018552975,0.0012391496,0.003494771],"category_scores_gemma":[0.0030230614,0.00040816606,0.0015848903,0.0065476187,0.00060352474,0.00082226534,0.00077790505,0.0013150828,0.00045565804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015078307,0.000050875966,0.9933106,0.0000352694,0.00021731346,0.00008043389,0.00021699328,0.00055435806,0.00009484871,0.00010547528,0.002459054,0.0027239164],"study_design_scores_gemma":[0.000007215862,0.000017059701,0.99813616,0.000013390134,0.00004460753,0.000028947414,0.00029343393,0.00092921936,0.000016738419,0.0000113218175,0.00049195683,0.000009909536],"about_ca_topic_score_codex":0.9943798,"about_ca_topic_score_gemma":0.9935133,"teacher_disagreement_score":0.025281508,"about_ca_system_score_codex":0.025281508,"about_ca_system_score_gemma":0.017375274,"threshold_uncertainty_score":0.18343103},"labels":[],"label_agreement":null},{"id":"W2977710227","doi":"10.1007/s40256-019-00373-1","title":"Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries","year":2019,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Mace; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Myocardial infarction; Acute coronary syndrome; Cardiology; Clinical endpoint; Randomized controlled trial","score_opus":0.006303911963001988,"score_gpt":0.19919777267439476,"score_spread":0.19289386071139278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977710227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708515,0.0006405406,0.00033116475,0.00007690208,0.000017066166,0.000022887003,0.001154987,0.000007347876,0.0006639548],"genre_scores_gemma":[0.9978811,0.00019840992,0.00014427706,0.000049383896,0.000037769674,0.000020165853,0.001553351,0.000008046759,0.00010737795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99524873,0.0019419383,0.00070398446,0.0010284401,0.00073335454,0.00034349877],"domain_scores_gemma":[0.9918834,0.0018861637,0.0038597626,0.0012987277,0.0006947165,0.00037731658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004613823,0.00036793418,0.0010284613,0.001402694,0.0003834182,0.0013760836,0.00057585986,0.0006686667,0.0011219356],"category_scores_gemma":[0.009754363,0.00034157676,0.0024402845,0.0026024834,0.00041988018,0.0009462103,0.0009946466,0.00086664094,0.00025754486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016652932,0.00005863204,0.99399203,0.00002607646,0.0015668566,0.00003987182,0.000053226322,0.00018921746,0.00017824699,0.00008803937,0.00030365604,0.0018389219],"study_design_scores_gemma":[0.00015399187,0.00030017682,0.9968983,0.000009350529,0.0008990708,0.00012621385,0.00009914889,0.00096253643,0.00007640655,0.00010002178,0.00036108235,0.000013799695],"about_ca_topic_score_codex":0.002636665,"about_ca_topic_score_gemma":0.003555601,"teacher_disagreement_score":0.004613823,"about_ca_system_score_codex":0.00043855573,"about_ca_system_score_gemma":0.0005814869,"threshold_uncertainty_score":0.024400473},"labels":[],"label_agreement":null},{"id":"W3067367675","doi":"10.1007/s40256-020-00428-8","title":"Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease","year":2020,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pharmacotherapy; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.021069936883145075,"score_gpt":0.34868845894899264,"score_spread":0.3276185220658476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3067367675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020147931,0.99914503,0.000047994385,0.00013265481,0.000080766884,0.0000046070413,0.000017649178,0.0000035313642,0.00036622875],"genre_scores_gemma":[0.0020026737,0.9971008,0.00015994503,0.00037077797,0.00015330274,0.0000068738545,0.000032396252,0.0000011540685,0.00017210585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999757,0.00005839076,0.00004383989,0.00003710463,0.00008444858,0.000019171472],"domain_scores_gemma":[0.99939394,0.00036962287,0.00011815502,0.000008649853,0.000079421356,0.000030170975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073209236,0.0007630003,0.002493171,0.0011760948,0.0001301086,0.0008035007,0.00077709195,0.0008358151,0.0033337304],"category_scores_gemma":[0.0012753936,0.00022057627,0.0011259409,0.0011675283,0.000233651,0.0005610548,0.00041602823,0.0018583686,0.0006977451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075132214,0.00019053822,0.00038391695,0.03380064,0.0009792696,0.00011482704,0.000025863337,0.00026196483,0.000835312,0.0007944766,0.00960514,0.9522567],"study_design_scores_gemma":[0.0027944003,0.003220024,0.023820126,0.06939265,0.01441363,0.003283862,0.00022539248,0.0013238831,0.0017114234,0.0038402837,0.8758061,0.00016825924],"about_ca_topic_score_codex":0.0011134136,"about_ca_topic_score_gemma":0.0033590645,"teacher_disagreement_score":0.0033337304,"about_ca_system_score_codex":0.00033004195,"about_ca_system_score_gemma":0.0007177359,"threshold_uncertainty_score":0.011152387},"labels":[],"label_agreement":null},{"id":"W3136802843","doi":"10.1007/s40256-021-00475-9","title":"Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries","year":2021,"lang":"en","type":"letter","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Cross-sectional study; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Anticoagulant therapy; Pharmacotherapy; Environmental health; Virology; Internal medicine; Outbreak; Pathology; Infectious disease (medical specialty)","score_opus":0.027529928524689714,"score_gpt":0.34924095989345677,"score_spread":0.32171103136876705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136802843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793937,0.0006220256,0.000100523386,0.012093947,0.00013838665,0.000021526055,0.004968274,0.00000941187,0.0026521692],"genre_scores_gemma":[0.98595077,0.0006250725,0.00023551157,0.00994457,0.00021520072,0.000045636323,0.001847548,0.0000075330863,0.0011282644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999191,0.00033442426,0.0001025353,0.000105765095,0.000107266445,0.00015890523],"domain_scores_gemma":[0.9969085,0.00072108477,0.0014373746,0.00015067859,0.00039725337,0.0003850556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008588151,0.00018459772,0.0002656248,0.00037438748,0.0005095238,0.00093111995,0.00033564825,0.0018642915,0.0018991857],"category_scores_gemma":[0.0035321235,0.00033192922,0.0005235431,0.0014289662,0.00032471682,0.0007089704,0.0005947871,0.0013753232,0.00044334796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000466137,0.000026396889,0.9951126,0.0000104450055,0.000057293197,0.00019805429,0.00013727914,0.000035317345,0.000027268705,0.000027869346,0.003008195,0.0013126417],"study_design_scores_gemma":[0.000011191345,0.00007308448,0.99646324,0.00002981895,0.00004072142,0.00035389274,0.0011487063,0.00017861994,0.000029744308,0.00003493374,0.0016272857,0.000008849208],"about_ca_topic_score_codex":0.032269966,"about_ca_topic_score_gemma":0.04813891,"teacher_disagreement_score":0.032269966,"about_ca_system_score_codex":0.00061626016,"about_ca_system_score_gemma":0.00087708497,"threshold_uncertainty_score":0.06416422},"labels":[],"label_agreement":null},{"id":"W3185695548","doi":"10.1007/s40256-021-00489-3","title":"The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery","year":2021,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Population Health Research Institute; Université de Montréal; Impact; Hamilton Health Sciences; Queen's University; McMaster University","funders":"","keywords":"Medicine; Dabigatran; Pharmacotherapy; Cardiac surgery; Cardiology; Surgery; Internal medicine; Atrial fibrillation; Warfarin","score_opus":0.0036022994011194296,"score_gpt":0.21216753228414847,"score_spread":0.20856523288302906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185695548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9354992,0.017207064,0.00030285722,0.027537702,0.0004554636,0.0000546944,0.0016870246,0.000008646206,0.017247414],"genre_scores_gemma":[0.99532735,0.0029077544,0.0001487424,0.00069371186,0.00025078998,0.000008441284,0.0003318257,0.0000026661926,0.00032863265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900216,0.00037556386,0.0001308206,0.000049024893,0.00018431884,0.00025812298],"domain_scores_gemma":[0.99740183,0.0007154973,0.00095626677,0.000055429962,0.00036032783,0.0005105827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005078137,0.00026627598,0.00031343588,0.0010325271,0.00071854796,0.0017417993,0.00043265332,0.0008914456,0.004191807],"category_scores_gemma":[0.009070034,0.00017439444,0.0010312663,0.001226563,0.00032133207,0.0008971637,0.0007612362,0.0016022696,0.00022479692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015570335,0.0003468117,0.9250038,0.0002888651,0.0006540017,0.0021427781,0.00020459412,0.0015729682,0.0002914107,0.0041080764,0.005875404,0.057954352],"study_design_scores_gemma":[0.00011189645,0.0004807295,0.9777233,0.0005509,0.0005844688,0.0041162833,0.0028090205,0.0038054972,0.00018477219,0.003976009,0.0056141154,0.000042930165],"about_ca_topic_score_codex":0.02064715,"about_ca_topic_score_gemma":0.03653558,"teacher_disagreement_score":0.02064715,"about_ca_system_score_codex":0.0031551565,"about_ca_system_score_gemma":0.002077997,"threshold_uncertainty_score":0.04105389},"labels":[],"label_agreement":null},{"id":"W32461932","doi":"10.2165/00129784-200101050-00001","title":"Antiatherosclerotic Effects of ACE Inhibitors","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Blood pressure; Internal medicine; ACE inhibitor; Endothelium; Aldosterone; Renin–angiotensin system; Heart failure; Clinical trial; Angiotensin-converting enzyme; Pharmacology","score_opus":0.018348154678419173,"score_gpt":0.2797059348951353,"score_spread":0.26135778021671613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32461932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002909986,0.99923253,0.000043272805,0.000048621336,0.00004650985,0.0000049875775,0.000023631175,0.000002860743,0.00030665926],"genre_scores_gemma":[0.0011117882,0.99840814,0.00015052367,0.00008846703,0.00006222392,0.000005210168,0.000024395647,6.470541e-7,0.00014856286],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999716,0.000054032553,0.00007600564,0.00003876195,0.00009749624,0.00001767082],"domain_scores_gemma":[0.9992913,0.0004409384,0.00015053173,0.000014478019,0.000076838114,0.000025885707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086870545,0.0008990532,0.0030412786,0.0020472344,0.00018512386,0.0006668135,0.0008586359,0.000621932,0.0030667114],"category_scores_gemma":[0.0012696958,0.00026723734,0.0009760537,0.0024867272,0.00024148269,0.0005949677,0.0003145156,0.0008011696,0.00057909597],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074486574,0.00015459019,0.00047156768,0.05000306,0.001293712,0.0002472296,0.000042846223,0.000166282,0.0014167336,0.0003380293,0.007958837,0.9371624],"study_design_scores_gemma":[0.0017204718,0.002349639,0.019490816,0.036913402,0.01971057,0.0051253214,0.0002679408,0.00033148652,0.004649746,0.0018126741,0.9075009,0.00012709267],"about_ca_topic_score_codex":0.0012597602,"about_ca_topic_score_gemma":0.0035929931,"teacher_disagreement_score":0.0030667114,"about_ca_system_score_codex":0.000285005,"about_ca_system_score_gemma":0.000593291,"threshold_uncertainty_score":0.010259211},"labels":[],"label_agreement":null},{"id":"W4220824635","doi":"10.1007/s40256-022-00526-9","title":"Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy","year":2022,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Transthyretin; Placebo; Internal medicine; Cardiomyopathy; Heart failure; Clinical trial; Pathology","score_opus":0.0018581874210486509,"score_gpt":0.17583553539002972,"score_spread":0.17397734796898107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220824635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965643,0.0029381237,0.00008585981,0.000062953535,0.000021135676,0.000019772895,0.000069660084,0.000004482535,0.00023362944],"genre_scores_gemma":[0.99904126,0.0005781844,0.00011722121,0.000035240588,0.000029054958,0.000023598503,0.00010355672,0.000001281988,0.00007053643],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989631,0.00056416355,0.00010980882,0.00014757436,0.0001181051,0.00009720111],"domain_scores_gemma":[0.9981711,0.0009381013,0.0005066921,0.000086569395,0.00008736659,0.00021019467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018675989,0.00030473413,0.0015682284,0.00027702074,0.00017637729,0.0004568075,0.00028342387,0.0005403236,0.0006702189],"category_scores_gemma":[0.0032567715,0.00016840576,0.0018925202,0.00036281432,0.0001892834,0.0002810232,0.000252319,0.00089856837,0.00006599303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48272708,0.0022948345,0.37411478,0.002047526,0.013094963,0.00050391,0.0003411992,0.0049296576,0.013616458,0.00025441783,0.0010841115,0.10499114],"study_design_scores_gemma":[0.020099096,0.087923154,0.86982715,0.00019889775,0.011626847,0.0008860545,0.0002235065,0.004747799,0.0026810463,0.00034013213,0.001390057,0.000056203004],"about_ca_topic_score_codex":0.00090513035,"about_ca_topic_score_gemma":0.0013509999,"teacher_disagreement_score":0.0018675989,"about_ca_system_score_codex":0.0003480728,"about_ca_system_score_gemma":0.00039058639,"threshold_uncertainty_score":0.009876907},"labels":[],"label_agreement":null},{"id":"W4307717083","doi":"10.1007/s40256-022-00554-5","title":"Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry","year":2022,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Rivaroxaban; Acute coronary syndrome; Ticagrelor; Aspirin; Internal medicine; Antithrombotic; Cohort; Randomized controlled trial; Clopidogrel; Warfarin; Emergency medicine; Cardiology; Intensive care medicine; Myocardial infarction; Atrial fibrillation","score_opus":0.011633990064880684,"score_gpt":0.2883962855430063,"score_spread":0.2767622954781256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307717083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979809,0.00031329555,0.00010145128,0.00027223091,0.000017159724,0.000015573229,0.0005759692,0.000005040568,0.0007184954],"genre_scores_gemma":[0.99876344,0.00011484649,0.00013762835,0.000098621924,0.000052384454,0.000017447843,0.0007242901,0.0000041278954,0.000087312124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692637,0.0012709572,0.00039717794,0.0005428173,0.0004466997,0.00041591868],"domain_scores_gemma":[0.9927603,0.0014468688,0.003669771,0.0006939366,0.00047604926,0.00095302786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029403905,0.00040770313,0.0009480326,0.0012637074,0.000901165,0.0021490166,0.0008334424,0.0006329251,0.0013759218],"category_scores_gemma":[0.007972861,0.0003811407,0.00097531924,0.002875231,0.0005274,0.0011447503,0.0013965546,0.00095071684,0.00017105209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002918314,0.00005417622,0.9981968,0.0000068904733,0.00009073865,0.00006377756,0.000055169196,0.000027134869,0.000088014625,0.00007473481,0.0002370632,0.00081368204],"study_design_scores_gemma":[0.000064368964,0.00008601591,0.9984106,0.000015359381,0.00010362052,0.00023446372,0.00033862432,0.00036886675,0.00005910006,0.00008164883,0.00022960952,0.000007711009],"about_ca_topic_score_codex":0.0048407624,"about_ca_topic_score_gemma":0.011353426,"teacher_disagreement_score":0.0048407624,"about_ca_system_score_codex":0.0005660634,"about_ca_system_score_gemma":0.0011013986,"threshold_uncertainty_score":0.015550435},"labels":[],"label_agreement":null},{"id":"W4353016809","doi":"10.1007/s40256-023-00576-7","title":"Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Veterans Affairs; Coronary artery disease; Internal medicine; Logistic regression; Odds ratio; Arterial disease; Cardiology; Vascular disease","score_opus":0.009363041760313886,"score_gpt":0.23838409481404813,"score_spread":0.22902105305373424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353016809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359,0.00096972816,0.000103635044,0.0004533228,0.000050232964,0.000010964445,0.0019438671,0.0000074426266,0.002870731],"genre_scores_gemma":[0.9982799,0.000244206,0.000047228168,0.00011112649,0.000033092958,0.0000052703535,0.00079996727,0.0000031778343,0.00047607027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992041,0.00008045477,0.00006864357,0.0001724878,0.00009006014,0.00038435863],"domain_scores_gemma":[0.9991543,0.00013253276,0.0003017397,0.00006828314,0.000090442176,0.00025275527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003506804,0.00018146464,0.00033452854,0.00057522324,0.0006251182,0.0007616281,0.000442497,0.00063950033,0.0050212666],"category_scores_gemma":[0.0015959532,0.00027948208,0.0008041196,0.0015746431,0.0001683202,0.00044640794,0.00064068567,0.0010670902,0.00027382374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015716511,0.00008002726,0.9966444,0.000013790681,0.00012753913,0.000036733192,0.00008115806,0.0000334041,0.00014440752,0.00013326084,0.00043955888,0.002108512],"study_design_scores_gemma":[0.000009559912,0.000028163553,0.9989944,0.000014713386,0.00004278478,0.00004772896,0.00024500734,0.00011782416,0.000032659416,0.00008607845,0.00037684894,0.0000042679494],"about_ca_topic_score_codex":0.041637182,"about_ca_topic_score_gemma":0.072037816,"teacher_disagreement_score":0.041637182,"about_ca_system_score_codex":0.0005064998,"about_ca_system_score_gemma":0.0010026519,"threshold_uncertainty_score":0.08278966},"labels":[],"label_agreement":null},{"id":"W4377093184","doi":"10.1007/s40256-023-00587-4","title":"Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Ticagrelor; Perioperative; Cohort; Cost effectiveness; Antithrombotic; Surgery; Anesthesia; Clopidogrel; Internal medicine; Aspirin","score_opus":0.015448452788350098,"score_gpt":0.28272705070754967,"score_spread":0.26727859791919956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377093184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98489517,0.0011880447,0.0074657816,0.0013262118,0.00003810051,0.00033166396,0.0016609567,0.000035948928,0.0030579865],"genre_scores_gemma":[0.9979115,0.00023355425,0.0011449384,0.00008464504,0.0000065255813,0.000080630794,0.000301221,0.0000030559854,0.00023393388],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99814284,0.0012554491,0.00006703589,0.00013291882,0.000118222364,0.00028347413],"domain_scores_gemma":[0.99414885,0.004500796,0.0006577859,0.00013745732,0.00022332493,0.0003318696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003849199,0.0010105256,0.0009266531,0.0010481287,0.00036943724,0.0013634572,0.0009409524,0.0012296981,0.0032329531],"category_scores_gemma":[0.010267318,0.00083170057,0.0032567887,0.0008470798,0.0005909495,0.0011569584,0.0010240772,0.0013454132,0.00012793399],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032430494,0.000428028,0.021258937,0.00014478371,0.00088775734,0.00013089889,0.00003281507,0.96366316,0.0004365769,0.0021866804,0.0005270825,0.0070601725],"study_design_scores_gemma":[0.0015879382,0.0031757192,0.027271507,0.0002040198,0.002140231,0.00025235064,0.00017603177,0.9598242,0.00095978886,0.0034659142,0.0008661006,0.000076214164],"about_ca_topic_score_codex":0.02161193,"about_ca_topic_score_gemma":0.012565102,"teacher_disagreement_score":0.02161193,"about_ca_system_score_codex":0.006562496,"about_ca_system_score_gemma":0.0040365765,"threshold_uncertainty_score":0.047614515},"labels":[],"label_agreement":null},{"id":"W4385442526","doi":"10.1007/s40256-023-00599-0","title":"Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy","year":2023,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Air Canada","funders":"","keywords":"Medicine; Pharmacotherapy; Hypertrophic cardiomyopathy; Internal medicine; Cardiology; Obstructive cardiomyopathy; Cardiomyopathy; Intensive care medicine; Heart failure","score_opus":0.03725592064992825,"score_gpt":0.31866510686583843,"score_spread":0.28140918621591016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031888808,0.9984376,0.000090419366,0.00020198517,0.00015757888,0.000009011639,0.000039528695,0.000012577183,0.0007323603],"genre_scores_gemma":[0.0029470052,0.994918,0.00029161497,0.0007934279,0.00024405087,0.000020021398,0.0000868387,0.000004069014,0.00069497904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984646,0.000031643816,0.000029188455,0.000030652838,0.000041684958,0.000020291927],"domain_scores_gemma":[0.99963987,0.0002054187,0.00006904506,0.000008794049,0.000044298074,0.00003259269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005893981,0.00087723,0.0023944278,0.0017333465,0.00026814055,0.00080470415,0.0009393217,0.0010144251,0.0058454867],"category_scores_gemma":[0.0007755972,0.00023718212,0.001104595,0.0012593133,0.00032256133,0.00075079245,0.000536417,0.0024113744,0.0014199804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006733464,0.0001823685,0.00022126944,0.020399429,0.000560992,0.0001881505,0.000040045878,0.0002185054,0.0016442244,0.0012495245,0.023796678,0.95082545],"study_design_scores_gemma":[0.0023100413,0.0024545335,0.0042053373,0.017160999,0.0046289475,0.002742699,0.00012236543,0.00042211663,0.0017392123,0.0023126565,0.96180576,0.000095402866],"about_ca_topic_score_codex":0.00072808407,"about_ca_topic_score_gemma":0.002271092,"teacher_disagreement_score":0.0058454867,"about_ca_system_score_codex":0.00034964486,"about_ca_system_score_gemma":0.00063399796,"threshold_uncertainty_score":0.019555092},"labels":[],"label_agreement":null},{"id":"W4386100303","doi":"10.1007/s40256-023-00604-6","title":"Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universidade de Santiago de Compostela; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Instituto de Investigación Sanitaria de Santiago de Compostela; Fundación Instituto de Investigación Sanitaria de Santiago de Compostela","keywords":"Alirocumab; Evolocumab; Medicine; PCSK9; Internal medicine; Observational study; Cognition; Cognitive decline; Cholesterol; Lipoprotein; Dementia; LDL receptor; Psychiatry; Disease","score_opus":0.026190719571995584,"score_gpt":0.3075683294849671,"score_spread":0.2813776099129715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386100303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986725,0.00028228748,0.000045454384,0.00005530071,0.0000089407995,0.00004224525,0.00065374654,0.000002934754,0.0002367249],"genre_scores_gemma":[0.9978728,0.00015718034,0.00010536158,0.00012730589,0.000034969442,0.00008068451,0.0013388793,0.0000026274724,0.00028019462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992662,0.00029203985,0.00007132488,0.00017340916,0.00010493692,0.000091995964],"domain_scores_gemma":[0.99855787,0.00017100137,0.00059343467,0.00020329005,0.00013306072,0.0003413198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018473538,0.0007084034,0.0009207416,0.0006409559,0.0005494538,0.0011512098,0.0006993115,0.000904075,0.0010535968],"category_scores_gemma":[0.0017585818,0.00046703834,0.0009451376,0.00096463447,0.0003882678,0.0008179001,0.00063602393,0.0010041139,0.0004967587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011004857,0.0014724314,0.98233324,0.00008377319,0.0010824414,0.00027227867,0.00026789252,0.00008774794,0.00056747126,0.000038577975,0.0004640547,0.002325218],"study_design_scores_gemma":[0.0016286745,0.0022985027,0.99425864,0.000021416883,0.0003890367,0.00023826603,0.00020521999,0.00028512767,0.00011016569,0.00005169797,0.0004914052,0.000021858797],"about_ca_topic_score_codex":0.0028371047,"about_ca_topic_score_gemma":0.0024978586,"teacher_disagreement_score":0.0028371047,"about_ca_system_score_codex":0.00049168133,"about_ca_system_score_gemma":0.0003780053,"threshold_uncertainty_score":0.009769857},"labels":[],"label_agreement":null},{"id":"W4388766983","doi":"10.1007/s40256-023-00618-0","title":"The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review","year":2023,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Coronary artery disease; Internal medicine; Percutaneous coronary intervention; Revascularization; Cardiology; Diabetes mellitus; Heart failure; Intensive care medicine; Myocardial infarction; Endocrinology","score_opus":0.0360141364876529,"score_gpt":0.28026528714409443,"score_spread":0.24425115065644154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388766983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032270755,0.9991726,0.000045071676,0.00011002947,0.00008959736,0.000034914225,0.00012409182,0.000003964218,0.00009694974],"genre_scores_gemma":[0.005215003,0.9938465,0.00017934603,0.0004901914,0.00007974828,0.0000462457,0.000074548814,0.0000023917307,0.00006599452],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99811363,0.00052268786,0.00064958486,0.00023998591,0.00036975645,0.0001043962],"domain_scores_gemma":[0.9932475,0.0047150482,0.0014235599,0.0000651306,0.00041999,0.00012874506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029260002,0.0010976703,0.009468368,0.0034257926,0.00032119668,0.0020384474,0.0016536689,0.0021232965,0.005280608],"category_scores_gemma":[0.011345186,0.00083585654,0.007682422,0.0041881124,0.0005446941,0.0014798027,0.00094803446,0.0019651009,0.00036121777],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008596942,0.000033904438,0.0007264134,0.9032369,0.029296014,0.0000850254,0.000086053165,0.00016381199,0.00019836001,0.00022094119,0.0039305673,0.061162457],"study_design_scores_gemma":[0.002334897,0.0005484581,0.008020808,0.6004453,0.35407373,0.0003499109,0.00027332382,0.000222961,0.00018973736,0.0005919731,0.032849193,0.000099724966],"about_ca_topic_score_codex":0.009023264,"about_ca_topic_score_gemma":0.028216934,"teacher_disagreement_score":0.009468368,"about_ca_system_score_codex":0.0016347193,"about_ca_system_score_gemma":0.0038088176,"threshold_uncertainty_score":0.017941475},"labels":[],"label_agreement":null},{"id":"W4390345179","doi":"10.1007/s40256-023-00620-6","title":"The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton General Hospital; Impact; McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"Boston Scientific Corporation; Novo Nordisk; Sanofi; Bayer; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Rivaroxaban; Medicine; Aspirin; Discontinuation; Cost effectiveness; Stroke (engine); Coronary artery disease; Regimen; Population; Myocardial infarction; Internal medicine; Surgery; Anesthesia; Warfarin; Atrial fibrillation","score_opus":0.04505284589782036,"score_gpt":0.33500516003062203,"score_spread":0.28995231413280165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390345179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.833018,0.10251979,0.007570474,0.01978073,0.0008821623,0.00072897394,0.012207399,0.000084989326,0.023207538],"genre_scores_gemma":[0.9902085,0.005219363,0.00108743,0.001419917,0.00017918288,0.00014524863,0.0012281486,0.000013078249,0.0004990582],"study_design_codex":"simulation_or_modeling","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99449086,0.004677036,0.00015381938,0.0002050603,0.00026091823,0.00021230131],"domain_scores_gemma":[0.99526584,0.0033832577,0.0007534105,0.00012191087,0.00023261982,0.00024290556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065586674,0.0009041215,0.0015417314,0.00096884783,0.00017916817,0.0020271305,0.00072070275,0.0012198874,0.0035869158],"category_scores_gemma":[0.012265081,0.00032841452,0.0046638385,0.0011422677,0.0004660075,0.0009900135,0.0006266993,0.0015190872,0.0001491903],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20998022,0.001634402,0.09496138,0.008614127,0.07437285,0.0025879694,0.00035571432,0.40725353,0.003208355,0.034838405,0.026581341,0.13561168],"study_design_scores_gemma":[0.070476465,0.038142573,0.18543439,0.008802723,0.10150897,0.0061768545,0.0013600828,0.46558258,0.004321134,0.077854306,0.039698906,0.0006410979],"about_ca_topic_score_codex":0.0073516876,"about_ca_topic_score_gemma":0.006821916,"teacher_disagreement_score":0.0073516876,"about_ca_system_score_codex":0.0033074913,"about_ca_system_score_gemma":0.002152454,"threshold_uncertainty_score":0.03468597},"labels":[],"label_agreement":null},{"id":"W4402674819","doi":"10.1007/s40256-024-00682-0","title":"Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients with Heterozygous Familial Hypercholesterolemia: A Meta-analysis","year":2024,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Place Centre; University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Kexin; Proprotein convertase; Medicine; Subtilisin; Familial hypercholesterolemia; Meta-analysis; PCSK9; Pharmacotherapy; Pharmacology; Internal medicine; Oncology; Cholesterol; LDL receptor; Lipoprotein; Enzyme; Biochemistry","score_opus":0.026719737743964984,"score_gpt":0.29411280833595066,"score_spread":0.2673930705919857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402674819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017068876,0.98091966,0.000552216,0.00019780509,0.00027544063,0.000066448585,0.00048078355,0.000039522212,0.00039925196],"genre_scores_gemma":[0.37488905,0.6192044,0.0015264563,0.0016050464,0.000517313,0.00018024401,0.0011834548,0.000042461572,0.0008515484],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9984981,0.0005862529,0.00036293778,0.00027366474,0.00016777216,0.00011140558],"domain_scores_gemma":[0.99825734,0.0011175377,0.0003279464,0.000087026194,0.00014395398,0.00006615125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028889878,0.0018658034,0.011427914,0.0012363272,0.00026584676,0.0015506934,0.0013635617,0.0014255804,0.0033014303],"category_scores_gemma":[0.004194041,0.0009649116,0.019336225,0.001793849,0.00032223001,0.00083332876,0.0006958715,0.00213571,0.0003130969],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023848442,0.00010250452,0.0076812254,0.10116041,0.8322457,0.00020934925,0.000058342903,0.00084249076,0.00092650176,0.00015808012,0.001744119,0.031022767],"study_design_scores_gemma":[0.0041053463,0.0005499584,0.009239329,0.0031431308,0.9802054,0.000099454985,0.000036714533,0.00026600587,0.00014803014,0.00021336495,0.001957763,0.00003546542],"about_ca_topic_score_codex":0.0032444166,"about_ca_topic_score_gemma":0.008491219,"teacher_disagreement_score":0.011427914,"about_ca_system_score_codex":0.0008550871,"about_ca_system_score_gemma":0.00074965967,"threshold_uncertainty_score":0.015278637},"labels":[],"label_agreement":null},{"id":"W4408622288","doi":"10.1007/s40256-025-00727-y","title":"Cardiovascular Safety Profile of Semaglutide and Variations by Sex, Race, and Kidney Function: A Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Semaglutide; Meta-analysis; Pharmacotherapy; Renal function; Internal medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes","score_opus":0.011901759979135762,"score_gpt":0.26119906985954283,"score_spread":0.24929730988040708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408622288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005509864,0.9931978,0.00035713468,0.000113993985,0.000109807654,0.00009015964,0.00040025674,0.00002086152,0.00020023594],"genre_scores_gemma":[0.11204448,0.88378936,0.0013854116,0.001120045,0.00021491127,0.00023603745,0.00070716185,0.000024201763,0.00047835498],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99822265,0.00056943,0.0005858883,0.0002913215,0.00022824101,0.000102426166],"domain_scores_gemma":[0.9966665,0.002239533,0.0006533527,0.00012432288,0.00024949506,0.000066811364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035203595,0.001980447,0.011950244,0.0021330116,0.00039114992,0.0018935384,0.0013672509,0.001597472,0.003851048],"category_scores_gemma":[0.007560185,0.00094203604,0.024999041,0.0032167137,0.0004278714,0.0011289556,0.0010092022,0.001704949,0.0003679447],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045619854,0.00006728922,0.0047045927,0.3083378,0.6508283,0.00016169564,0.000072637544,0.00056118163,0.00051070406,0.00013725495,0.0014137967,0.028642684],"study_design_scores_gemma":[0.0010352246,0.00023809436,0.0043999287,0.009318354,0.98259485,0.00009196644,0.00003757039,0.00013951509,0.000111343405,0.0001715682,0.0018305512,0.000031006974],"about_ca_topic_score_codex":0.0048043556,"about_ca_topic_score_gemma":0.016218774,"teacher_disagreement_score":0.011950244,"about_ca_system_score_codex":0.001099075,"about_ca_system_score_gemma":0.0016689299,"threshold_uncertainty_score":0.01861763},"labels":[],"label_agreement":null},{"id":"W4411698506","doi":"10.1007/s40256-025-00740-1","title":"A Drug–Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers","year":2025,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Drug; Pharmacotherapy; Pharmacokinetics; Pharmacology; Rosuvastatin Calcium; Drug interaction; Drug-drug interaction; Internal medicine","score_opus":0.0394081592109647,"score_gpt":0.37937407008664825,"score_spread":0.33996591087568356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411698506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875176,0.00046590154,0.00022413567,0.000027842161,0.00001589535,0.00013181736,0.00011243346,0.0000111508025,0.00025895468],"genre_scores_gemma":[0.9986669,0.00020205199,0.00034235467,0.00005955139,0.00003065606,0.000089375484,0.00020247577,0.0000039413667,0.00040275409],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990319,0.00048327184,0.00006424694,0.00017114326,0.00015898343,0.00009046354],"domain_scores_gemma":[0.9986228,0.0005458035,0.0003642787,0.000109606546,0.00010745828,0.0002499929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017152644,0.00071269285,0.0015352118,0.00029016804,0.00043054743,0.0004753357,0.00023109448,0.00064110995,0.0015976918],"category_scores_gemma":[0.0022716506,0.0003271508,0.0013170795,0.00038524906,0.00029946413,0.00040681558,0.0003192739,0.00074876397,0.0002023182],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6005162,0.01888772,0.21978508,0.0010172183,0.012383859,0.0017206272,0.000803372,0.0012431733,0.08799819,0.00026314627,0.000934266,0.054447114],"study_design_scores_gemma":[0.020857807,0.31354842,0.6356292,0.000029218514,0.0077919094,0.0014615788,0.00025637576,0.0066601,0.010087028,0.00022806926,0.0033397279,0.00011062491],"about_ca_topic_score_codex":0.00094756176,"about_ca_topic_score_gemma":0.0013178907,"teacher_disagreement_score":0.0017152644,"about_ca_system_score_codex":0.00040316573,"about_ca_system_score_gemma":0.0005135997,"threshold_uncertainty_score":0.009071231},"labels":[],"label_agreement":null},{"id":"W4416276341","doi":"10.1007/s40256-025-00777-2","title":"Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly","year":2025,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Insulin resistance; Pharmacotherapy; Type 2 Diabetes Mellitus; Diabetes mellitus; Disease; Narrative review; Type 2 diabetes; Adverse effect; Thiazide","score_opus":0.0038628162712345195,"score_gpt":0.22686060347112072,"score_spread":0.2229977871998862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003509037,0.6936169,0.00048403465,0.29056785,0.0057384693,0.000011082077,0.00008336255,0.000029678002,0.005959622],"genre_scores_gemma":[0.13507645,0.6647107,0.0017692354,0.15297534,0.04012012,0.000031442032,0.0000890423,0.000042785967,0.005184921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919248,0.0041882456,0.00057773513,0.00034990947,0.0026155873,0.00034371394],"domain_scores_gemma":[0.9818394,0.010411697,0.0027980094,0.0008151506,0.002633687,0.0015019203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010846079,0.0007374356,0.0026304515,0.001802727,0.0020978905,0.007906607,0.0011460896,0.00727007,0.0063872067],"category_scores_gemma":[0.01819501,0.0005119994,0.0010826044,0.0020566394,0.006015687,0.008434031,0.0027503413,0.009859501,0.0013356992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017848759,0.000824979,0.035211887,0.0045463187,0.0014592385,0.0007316863,0.0009967298,0.00075841194,0.0010948428,0.042936068,0.19140555,0.71824944],"study_design_scores_gemma":[0.00069568516,0.0017875655,0.119768344,0.017880352,0.0017108999,0.002773424,0.006564031,0.002770996,0.0007920096,0.1827894,0.66202223,0.00044506695],"about_ca_topic_score_codex":0.0053510675,"about_ca_topic_score_gemma":0.01442122,"teacher_disagreement_score":0.010846079,"about_ca_system_score_codex":0.0019251691,"about_ca_system_score_gemma":0.0039675785,"threshold_uncertainty_score":0.057360232},"labels":[],"label_agreement":null},{"id":"W68433167","doi":"10.2165/00129784-200101020-00002","title":"Patients With Atherosclerotic Vascular Disease","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Homocysteine; Medicine; Internal medicine; Vascular disease; B vitamins; Fibrinogen; Risk factor; Vitamin B12; Endocrinology; Cyanocobalamin; Endothelial dysfunction; Pyridoxine; Stroke (engine); Niacin","score_opus":0.016297677009114234,"score_gpt":0.28324268598161384,"score_spread":0.2669450089724996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W68433167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047308445,0.9977077,0.000086431304,0.00025496894,0.00027759065,0.0000072670405,0.000026926455,0.000006220188,0.0011597597],"genre_scores_gemma":[0.0036975096,0.994265,0.00020082537,0.0005088194,0.00032577253,0.000015142023,0.000072865,8.9051827e-7,0.0009132279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980503,0.000044713095,0.00003607789,0.000037875852,0.00005528813,0.000021010319],"domain_scores_gemma":[0.99978536,0.000093363684,0.00005220194,0.000007776215,0.000040155104,0.00002113442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041335038,0.0008376298,0.0023639717,0.0012990055,0.0002839632,0.00045045963,0.0005093837,0.00072671566,0.0041460725],"category_scores_gemma":[0.00091317645,0.00018679893,0.0005453736,0.0015558995,0.00017966273,0.0005408896,0.00042547839,0.00079201855,0.0011921098],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040114854,0.00016098116,0.0022287464,0.014586051,0.00045309213,0.000403153,0.000041995365,0.0000655624,0.0007009745,0.00047023786,0.032151647,0.94833636],"study_design_scores_gemma":[0.00081050675,0.0011427705,0.031338874,0.02410183,0.0059310864,0.0100647565,0.00026347564,0.0002313552,0.0012665504,0.001448426,0.92333037,0.00006991984],"about_ca_topic_score_codex":0.0011677119,"about_ca_topic_score_gemma":0.0032406421,"teacher_disagreement_score":0.0041460725,"about_ca_system_score_codex":0.00019140301,"about_ca_system_score_gemma":0.00074395136,"threshold_uncertainty_score":0.013870001},"labels":[],"label_agreement":null},{"id":"W79675979","doi":"10.2165/00129784-200606050-00006","title":"The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study)","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo","keywords":"Olmesartan; Medicine; Internal medicine; Angiotensin II; Cardiology; Angiotensin II receptor type 1; Vascular resistance; Blockade; Atenolol; Essential hypertension; Urology; Blood pressure; Endocrinology; Receptor","score_opus":0.004372642364146629,"score_gpt":0.2060415327259775,"score_spread":0.20166889036183086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79675979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594337,0.0017772726,0.000119606564,0.00021978149,0.00006593841,0.00007865623,0.00044128066,0.000013702194,0.0013404245],"genre_scores_gemma":[0.9947778,0.0018277864,0.00043784137,0.00038181068,0.00033984502,0.000114075956,0.0009806916,0.000014498525,0.0011255877],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996375,0.00018304613,0.000019674902,0.000047210786,0.000040607094,0.00007193117],"domain_scores_gemma":[0.999131,0.00020559963,0.00019913037,0.00011521254,0.000031234635,0.0003178276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014981484,0.0009518476,0.001348298,0.00027959986,0.00030983827,0.0007983293,0.00048765115,0.0008557828,0.0021261384],"category_scores_gemma":[0.0013120464,0.00046203376,0.0014622785,0.00028899964,0.0006233099,0.0006996528,0.0006780169,0.0016720957,0.00027662274],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79502046,0.009268135,0.11574422,0.00089077716,0.0059302486,0.00047895836,0.00027147264,0.0004388815,0.021792555,0.00057372684,0.0020769252,0.047513597],"study_design_scores_gemma":[0.19947661,0.14434355,0.6322376,0.00016653776,0.011696666,0.00050798926,0.00032442383,0.00071247364,0.0044991877,0.0007371904,0.0051895385,0.00010838927],"about_ca_topic_score_codex":0.0010065343,"about_ca_topic_score_gemma":0.0021159279,"teacher_disagreement_score":0.0021261384,"about_ca_system_score_codex":0.00021571523,"about_ca_system_score_gemma":0.0006160987,"threshold_uncertainty_score":0.007923067},"labels":[],"label_agreement":null},{"id":"W940111687","doi":"10.2165/00129784-200404040-00001","title":"Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Heart failure; Carnitine; Beta oxidation; Medicine; Fatty acid metabolism; Diabetic cardiomyopathy; Internal medicine; Diabetes mellitus; Fatty acid; Heart disease; Metabolism; Cardiomyopathy; Endocrinology; Pharmacology; Cardiology; Biochemistry; Chemistry","score_opus":0.018183394067316703,"score_gpt":0.2860817668543604,"score_spread":0.26789837278704365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W940111687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015937792,0.9988819,0.000114684866,0.00021185544,0.00016640671,0.0000041278972,0.000013702303,0.000006463429,0.00044156046],"genre_scores_gemma":[0.0006600417,0.99825245,0.00023235196,0.00017271675,0.0001526782,0.0000063914313,0.000036175024,0.0000010141666,0.0004861675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985933,0.00001855539,0.00002181365,0.000025012383,0.00005908628,0.000016124339],"domain_scores_gemma":[0.99976605,0.00008202991,0.00004278358,0.0000061782894,0.00006906787,0.00003378481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056134816,0.001043899,0.0023733522,0.0015336047,0.0002736481,0.00069772976,0.0009637383,0.0010283533,0.0026622354],"category_scores_gemma":[0.00041638134,0.00025286907,0.00044456552,0.0015679902,0.00038035,0.0009308764,0.00052647333,0.001839223,0.0021829128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003149752,0.00014468844,0.00021973634,0.010548844,0.00020834677,0.00033288973,0.00003108554,0.00025617096,0.0027820573,0.0011189381,0.026218425,0.95782375],"study_design_scores_gemma":[0.00022262525,0.00032140446,0.001976096,0.002260316,0.00048940367,0.0020723783,0.00006988286,0.00017423402,0.0012235541,0.0010774909,0.99008477,0.000027853606],"about_ca_topic_score_codex":0.0016849219,"about_ca_topic_score_gemma":0.0042023957,"teacher_disagreement_score":0.0026622354,"about_ca_system_score_codex":0.000586212,"about_ca_system_score_gemma":0.0011424288,"threshold_uncertainty_score":0.008906066},"labels":[],"label_agreement":null}]}